SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '499'


List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4G_A_ZMRA466_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.74A 1a4gA-3silA:
23.5		 1a4gA-3silA:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4G_B_ZMRB466_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		5 / 12 ARG A  37
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.53A 1a4gB-3silA:
23.5		 1a4gB-3silA:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CMA_B_SAMB105_0
(PROTEIN (MET
REPRESSOR))		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		5 / 11 GLU A 376
GLU A 378
LEU A 381
ALA A 501
GLY A 499
 GLU  A 376 ( 0.6A)
GLU  A 378 ( 0.6A)
LEU  A 381 ( 0.6A)
ALA  A 501 ( 0.0A)
GLY  A 499 ( 0.0A)
 1.23A 1cmaA-4flxA:
undetectable
1cmaB-4flxA:
undetectable		 1cmaA-4flxA:
10.19
1cmaB-4flxA:
10.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DB1_A_VDXA428_1
(VITAMIN D NUCLEAR
RECEPTOR)		 3pop GILR OXIDASE
(Streptomyces
griseoflavus) 		5 / 12 LEU A 112
LEU A 216
SER A 205
VAL A 108
LEU A 133
 None
None
None
None
FAD  A 499 (-4.0A)
 1.33A 1db1A-3popA:
undetectable		 1db1A-3popA:
17.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EKJ_H_ACTH3006_0
(BETA-CARBONIC
ANHYDRASE)		 1cc1 HYDROGENASE (LARGE
SUBUNIT)
(Desulfomicrobium
baculatum) 		4 / 6 CYH L  73
VAL L  72
HIS L  77
CYH L 495
 FCO  L 499 ( 2.2A)
NI  L 500 ( 4.9A)
FCO  L 499 (-3.9A)
FCO  L 499 (-2.3A)
 1.29A 1ekjG-1cc1L:
undetectable
1ekjH-1cc1L:
undetectable		 1ekjG-1cc1L:
17.33
1ekjH-1cc1L:
17.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FM6_D_BRLD503_1
(PEROXISOME
PROLIFERATOR
ACTIVATED RECEPTOR
GAMMA)		 1cc1 HYDROGENASE (LARGE
SUBUNIT)
(Desulfomicrobium
baculatum) 		5 / 12 CYH L 492
HIS L 498
HIS L  77
LEU L 428
LEU L 449
 NI  L 500 (-2.4A)
FE2  L 501 (-3.5A)
FCO  L 499 (-3.9A)
FCO  L 499 (-3.5A)
None
 1.30A 1fm6D-1cc1L:
0.0		 1fm6D-1cc1L:
19.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FM6_X_BRLX504_1
(PEROXISOME
PROLIFERATOR
ACTIVATED RECEPTOR
GAMMA)		 1cc1 HYDROGENASE (LARGE
SUBUNIT)
(Desulfomicrobium
baculatum) 		5 / 12 CYH L 492
HIS L 498
HIS L  77
LEU L 428
LEU L 449
 NI  L 500 (-2.4A)
FE2  L 501 (-3.5A)
FCO  L 499 (-3.9A)
FCO  L 499 (-3.5A)
None
 1.30A 1fm6X-1cc1L:
0.0		 1fm6X-1cc1L:
19.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GTI_A_CCSA47_0
(GLUTATHIONE
S-TRANSFERASE)		 3hhe RIBOSE-5-PHOSPHATE
ISOMERASE A
(Bartonella
henselae) 		4 / 7 LEU A  45
LEU A  59
GLY A  61
LEU A  68
 None
None
None
CL  A 499 ( 4.7A)
 0.80A 1gtiA-3hheA:
undetectable		 1gtiA-3hheA:
21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HO5_A_ADNA1604_1
(5'-NUCLEOTIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		5 / 11 ARG A 246
SER A 248
GLY A 279
ARG A 309
ASN A 305
 PO4  A 499 (-2.7A)
None
None
PO4  A 499 (-3.0A)
None
 1.02A 1ho5A-3silA:
undetectable		 1ho5A-3silA:
21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HZE_A_RBFA98_1
(RIBOFLAVIN SYNTHASE
ALPHA CHAIN)		 1k4q GLUTATHIONE
REDUCTASE
(Homo
sapiens) 		5 / 9 LEU A  33
LEU A 118
ILE A 126
THR A 156
ILE A  26
 NIY  A 114 ( 4.1A)
NIY  A 114 ( 3.9A)
None
FAD  A 499 (-3.9A)
None
 1.38A 1hzeA-1k4qA:
0.0
1hzeB-1k4qA:
0.0		 1hzeA-1k4qA:
13.43
1hzeB-1k4qA:
13.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HZE_B_RBFB99_1
(RIBOFLAVIN SYNTHASE
ALPHA CHAIN)		 1k4q GLUTATHIONE
REDUCTASE
(Homo
sapiens) 		5 / 9 THR A 156
ILE A  26
LEU A  33
LEU A 118
ILE A 126
 FAD  A 499 (-3.9A)
None
NIY  A 114 ( 4.1A)
NIY  A 114 ( 3.9A)
None
 1.38A 1hzeA-1k4qA:
0.0
1hzeB-1k4qA:
0.0		 1hzeA-1k4qA:
13.43
1hzeB-1k4qA:
13.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1IEP_A_STIA201_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 LEU A 251
ALA A 271
GLU A 288
MET A 292
THR A 316
PHE A 318
GLY A 322
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
 0.98A 1iepA-2hk5A:
27.5		 1iepA-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1IEP_A_STIA201_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 LEU A 251
ALA A 271
MET A 292
THR A 316
PHE A 318
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.95A 1iepA-2hk5A:
27.5		 1iepA-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1IEP_A_STIA201_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 LEU A 251
VAL A 259
ALA A 271
GLU A 288
MET A 292
THR A 316
PHE A 318
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
 1.01A 1iepA-2hk5A:
27.5		 1iepA-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1IEP_A_STIA201_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 LEU A 251
VAL A 259
ALA A 271
MET A 292
THR A 316
PHE A 318
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 1.04A 1iepA-2hk5A:
27.5		 1iepA-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1IEP_A_STIA201_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 6 LYS A 273
VAL A 291
VAL A 301
ILE A 314
 1BM  A 499 (-3.8A)
None
None
1BM  A 499 (-3.9A)
 0.68A 1iepA-2hk5A:
27.4		 1iepA-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1IEP_A_STIA201_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 6 VAL A 291
VAL A 301
ILE A 314
MET A 319
ARG A 363
 None
None
1BM  A 499 (-3.9A)
None
None
 1.01A 1iepA-2hk5A:
27.4		 1iepA-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1IEP_B_STIB202_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 LEU A 251
ALA A 271
MET A 292
THR A 316
PHE A 318
GLY A 322
ALA A 381
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 ( 3.7A)
 0.98A 1iepB-2hk5A:
27.6		 1iepB-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1IEP_B_STIB202_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 LEU A 251
VAL A 259
ALA A 271
GLU A 288
MET A 292
THR A 316
PHE A 318
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
 0.67A 1iepB-2hk5A:
27.6		 1iepB-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1IEP_B_STIB202_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 LEU A 251
VAL A 259
ALA A 271
MET A 292
THR A 316
PHE A 318
ALA A 381
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 1.02A 1iepB-2hk5A:
27.6		 1iepB-2hk5A:
46.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LQP_A_FCNA4002_1
(PROBABLE FOSFOMYCIN
RESISTANCE PROTEIN)		 5fzo PROBABLE JMJC
DOMAIN-CONTAINING
HISTONE
DEMETHYLATION PROT
EIN 2C
(Homo
sapiens) 		5 / 10 HIS A2336
GLU A2338
HIS A2466
THR A2333
TRP A2391
 MN  A3499 (-3.4A)
MN  A3499 (-2.5A)
MN  A3499 (-3.4A)
None
None
 1.20A 1lqpA-5fzoA:
0.0
1lqpB-5fzoA:
0.0		 1lqpA-5fzoA:
19.32
1lqpB-5fzoA:
19.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LQP_B_FCNB4001_1
(PROBABLE FOSFOMYCIN
RESISTANCE PROTEIN)		 5fzo PROBABLE JMJC
DOMAIN-CONTAINING
HISTONE
DEMETHYLATION PROT
EIN 2C
(Homo
sapiens) 		5 / 10 HIS A2466
THR A2333
TRP A2391
HIS A2336
GLU A2338
 MN  A3499 (-3.4A)
None
None
MN  A3499 (-3.4A)
MN  A3499 (-2.5A)
 1.20A 1lqpA-5fzoA:
0.0
1lqpB-5fzoA:
0.0		 1lqpA-5fzoA:
19.32
1lqpB-5fzoA:
19.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1M17_A_AQ4A999_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 LEU A 251
ALA A 271
LYS A 273
GLU A 288
THR A 316
MET A 319
GLY A 322
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.2A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.44A 1m17A-2hk5A:
27.8		 1m17A-2hk5A:
34.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MAA_D_DMED999_1
(ACETYLCHOLINESTERASE)		 5mc5 XAA-PRO DIPEPTIDASE
(Homo
sapiens) 		4 / 8 TRP A 326
GLY A 367
TYR A 382
HIS A 370
 None
None
GOL  A 506 ( 4.5A)
MN  A 499 ( 3.6A)
 1.08A 1maaD-5mc5A:
undetectable		 1maaD-5mc5A:
12.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJ2_A_SAMA2200_0
(PROTEIN (METHIONINE
REPRESSOR))		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		5 / 12 ALA A 501
GLY A 499
GLU A 376
GLU A 378
LEU A 381
 ALA  A 501 ( 0.0A)
GLY  A 499 ( 0.0A)
GLU  A 376 ( 0.6A)
GLU  A 378 ( 0.6A)
LEU  A 381 ( 0.6A)
 1.22A 1mj2A-4flxA:
undetectable
1mj2B-4flxA:
undetectable		 1mj2A-4flxA:
10.36
1mj2B-4flxA:
10.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJO_C_SAMC200_0
(METHIONINE REPRESSOR)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		5 / 12 ALA A 501
GLY A 499
GLU A 376
GLU A 378
LEU A 381
 ALA  A 501 ( 0.0A)
GLY  A 499 ( 0.0A)
GLU  A 376 ( 0.6A)
GLU  A 378 ( 0.6A)
LEU  A 381 ( 0.6A)
 1.27A 1mjoC-4flxA:
undetectable
1mjoD-4flxA:
undetectable		 1mjoC-4flxA:
10.36
1mjoD-4flxA:
10.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJQ_C_SAMC199_0
(METHIONINE REPRESSOR)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		5 / 10 GLU A 376
GLU A 378
LEU A 381
ALA A 501
GLY A 499
 GLU  A 376 ( 0.6A)
GLU  A 378 ( 0.6A)
LEU  A 381 ( 0.6A)
ALA  A 501 ( 0.0A)
GLY  A 499 ( 0.0A)
 1.22A 1mjqC-4flxA:
undetectable
1mjqD-4flxA:
undetectable		 1mjqC-4flxA:
10.36
1mjqD-4flxA:
10.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJQ_I_SAMI199_0
(METHIONINE REPRESSOR)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		5 / 11 GLU A 376
GLU A 378
LEU A 381
ALA A 501
GLY A 499
 GLU  A 376 ( 0.6A)
GLU  A 378 ( 0.6A)
LEU  A 381 ( 0.6A)
ALA  A 501 ( 0.0A)
GLY  A 499 ( 0.0A)
 1.21A 1mjqI-4flxA:
undetectable
1mjqJ-4flxA:
undetectable		 1mjqI-4flxA:
10.36
1mjqJ-4flxA:
10.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MXD_A_ACRA732_1
(ALPHA AMYLASE)		 1k4q GLUTATHIONE
REDUCTASE
(Homo
sapiens) 		5 / 9 GLY A  62
GLY A 158
GLY A 157
ASP A 331
ARG A 291
 FAD  A 499 ( 3.7A)
None
FAD  A 499 (-3.4A)
FAD  A 499 (-2.9A)
FAD  A 499 (-3.8A)
 1.11A 1mxdA-1k4qA:
1.1		 1mxdA-1k4qA:
21.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N2X_B_SAMB402_0
(S-ADENOSYL-METHYLTRA
NSFERASE MRAW)		 4b61 ALGINATE PRODUCTION
PROTEIN ALGE
(Pseudomonas
aeruginosa) 		5 / 12 GLY A 462
GLU A 368
GLY A 463
HIS A 480
GLY A  50
 78M  A1493 (-3.9A)
None
78M  A1493 (-3.7A)
78M  A1493 (-4.0A)
78M  A1499 ( 4.3A)
 0.95A 1n2xB-4b61A:
undetectable		 1n2xB-4b61A:
20.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NNC_A_ZMRA479_1
(NEURAMINIDASE N9)		 3sil SIALIDASE
(Salmonella
enterica) 		5 / 12 ARG A  37
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.62A 1nncA-3silA:
13.0		 1nncA-3silA:
22.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OPJ_A_STIA3_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 LEU A 251
ALA A 271
MET A 292
VAL A 301
THR A 316
PHE A 318
ALA A 381
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.89A 1opjA-2hk5A:
26.5		 1opjA-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OPJ_A_STIA3_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 LEU A 251
VAL A 259
ALA A 271
GLU A 288
MET A 292
VAL A 301
THR A 316
PHE A 318
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
 0.63A 1opjA-2hk5A:
26.5		 1opjA-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OPJ_A_STIA3_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 LEU A 251
VAL A 259
ALA A 271
MET A 292
VAL A 301
THR A 316
PHE A 318
LEU A 371
ALA A 381
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.88A 1opjA-2hk5A:
26.5		 1opjA-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OPJ_A_STIA3_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 5 LYS A 273
VAL A 291
ILE A 314
MET A 319
 1BM  A 499 (-3.8A)
None
1BM  A 499 (-3.9A)
None
 0.67A 1opjA-2hk5A:
26.4		 1opjA-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OPJ_B_STIB4_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 ALA A 271
MET A 292
VAL A 301
THR A 316
PHE A 318
GLY A 322
ALA A 381
 1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 ( 3.7A)
 0.79A 1opjB-2hk5A:
26.3		 1opjB-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OPJ_B_STIB4_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 VAL A 259
ALA A 271
GLU A 288
MET A 292
VAL A 301
THR A 316
PHE A 318
ALA A 381
ASP A 382
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.96A 1opjB-2hk5A:
26.3		 1opjB-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OPJ_B_STIB4_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 6 LEU A 251
LYS A 273
VAL A 291
ILE A 314
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.8A)
None
1BM  A 499 (-3.9A)
 0.56A 1opjB-2hk5A:
26.3		 1opjB-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OPJ_B_STIB4_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 6 LEU A 251
VAL A 291
ILE A 314
MET A 319
 1BM  A 499 ( 3.7A)
None
1BM  A 499 (-3.9A)
None
 0.69A 1opjB-2hk5A:
26.3		 1opjB-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OPJ_B_STIB4_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 6 LYS A 273
VAL A 291
ILE A 314
ARG A 363
 1BM  A 499 (-3.8A)
None
1BM  A 499 (-3.9A)
None
 1.02A 1opjB-2hk5A:
26.3		 1opjB-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OPJ_B_STIB4_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 6 VAL A 291
ILE A 314
MET A 319
ARG A 363
 None
1BM  A 499 (-3.9A)
None
None
 0.98A 1opjB-2hk5A:
26.3		 1opjB-2hk5A:
46.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P9G_A_ACTA42_0
(EAFP 2)		 1cc1 HYDROGENASE (LARGE
SUBUNIT)
(Desulfomicrobium
baculatum) 		3 / 3 CYH L  73
ARG L 425
CYH L  70
 FCO  L 499 ( 2.2A)
FCO  L 499 (-4.1A)
NI  L 500 ( 2.2A)
 1.47A 1p9gA-1cc1L:
undetectable		 1p9gA-1cc1L:
6.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QKN_A_RALA600_1
(ESTROGEN RECEPTOR
BETA)		 1k4q GLUTATHIONE
REDUCTASE
(Homo
sapiens) 		6 / 12 ALA A 155
LEU A 153
LEU A  24
ILE A 125
ILE A 123
LEU A  33
 FAD  A 499 (-4.5A)
None
None
None
None
NIY  A 114 ( 4.1A)
 1.25A 1qknA-1k4qA:
undetectable		 1qknA-1k4qA:
18.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QZZ_A_ACTA421_0
(ACLACINOMYCIN-10-HYD
ROXYLASE)		 3pop GILR OXIDASE
(Streptomyces
griseoflavus) 		5 / 8 TYR A 201
GLY A 136
GLY A 132
GLY A 131
LEU A 133
 None
None
FAD  A 499 (-3.2A)
FAD  A 499 (-3.5A)
FAD  A 499 (-4.0A)
 0.98A 1qzzA-3popA:
undetectable		 1qzzA-3popA:
24.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SN5_D_T3D602_1
(TRANSTHYRETIN)		 2j4d CRYPTOCHROME DASH
(Arabidopsis
thaliana) 		5 / 12 LEU A  50
LEU A 102
LEU A  78
GLU A 149
LEU A  74
 None
None
None
MHF  A1499 (-2.8A)
None
 1.08A 1sn5B-2j4dA:
undetectable
1sn5D-2j4dA:
undetectable		 1sn5B-2j4dA:
14.34
1sn5D-2j4dA:
14.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SN5_D_T3D602_1
(TRANSTHYRETIN)		 2j4d CRYPTOCHROME DASH
(Arabidopsis
thaliana) 		5 / 12 LEU A  78
GLU A 149
LEU A  74
LEU A  50
LEU A 102
 None
MHF  A1499 (-2.8A)
None
None
None
 1.10A 1sn5B-2j4dA:
undetectable
1sn5D-2j4dA:
undetectable		 1sn5B-2j4dA:
14.34
1sn5D-2j4dA:
14.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T46_A_STIA3_1
(HOMO SAPIENS V-KIT
HARDY-ZUCKERMAN 4
FELINE SARCOMA VIRAL
ONCOGENE HOMOLOG)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 LEU A 251
VAL A 259
ALA A 271
LYS A 273
GLU A 288
VAL A 301
THR A 316
GLY A 322
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.90A 1t46A-2hk5A:
25.0		 1t46A-2hk5A:
38.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T46_A_STIA3_1
(HOMO SAPIENS V-KIT
HARDY-ZUCKERMAN 4
FELINE SARCOMA VIRAL
ONCOGENE HOMOLOG)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 LEU A 251
VAL A 259
ALA A 271
LYS A 273
GLU A 288
VAL A 301
THR A 316
LEU A 371
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-4.4A)
1BM  A 499 (-4.4A)
 0.84A 1t46A-2hk5A:
25.0		 1t46A-2hk5A:
38.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1TDN_A_LEUA487_0
(L-AMINO ACID OXIDASE)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 7 ASN A 369
HIS A 362
PHE A 383
ILE A 348
 1BM  A 499 (-4.1A)
None
None
None
 1.16A 1tdnA-2hk5A:
undetectable		 1tdnA-2hk5A:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1V3E_B_ZMRB2200_1
(HEMAGGLUTININ-NEURAM
INIDASE GLYCOPROTEIN)		 3sil SIALIDASE
(Salmonella
enterica) 		5 / 10 ARG A  37
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.92A 1v3eB-3silA:
26.3		 1v3eB-3silA:
21.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XBB_A_STIA1_1
(TYROSINE-PROTEIN
KINASE SYK)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 9 LEU A 251
VAL A 259
ALA A 271
GLY A 322
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.39A 1xbbA-2hk5A:
35.0		 1xbbA-2hk5A:
36.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XKK_A_FMMA91_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 ALA A 271
THR A 316
GLY A 322
LEU A 325
ASP A 326
LEU A 371
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
None
None
1BM  A 499 (-4.4A)
 0.66A 1xkkA-2hk5A:
25.3		 1xkkA-2hk5A:
32.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XKK_A_FMMA91_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 THR A 316
GLY A 322
LEU A 325
ASP A 326
LEU A 371
ASP A 382
 1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
None
None
1BM  A 499 (-4.4A)
1BM  A 499 (-4.4A)
 0.76A 1xkkA-2hk5A:
25.3		 1xkkA-2hk5A:
32.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XVA_A_SAMA293_0
(GLYCINE
N-METHYLTRANSFERASE)		 3snx PUTATIVE SUSD-LIKE
CARBOHYDRATE BINDING
PROTEIN
(Bacteroides
thetaiotaomicron) 		5 / 12 ASP A  99
HIS A 152
ARG A  70
GLY A 414
TYR A  69
 None
None
None
None
EDO  A 499 (-4.5A)
 1.44A 1xvaA-3snxA:
undetectable		 1xvaA-3snxA:
19.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2AKE_A_TRPA479_0
(TRYPTOPHANYL-TRNA
SYNTHETASE)		 3g25 GLYCEROL KINASE
(Staphylococcus
aureus) 		5 / 12 THR A 266
GLY A 265
GLY A 409
THR A 263
GLN A 245
 PO4  A 502 ( 3.4A)
PO4  A 502 (-3.3A)
None
None
GOL  A 499 (-4.0A)
 1.23A 2akeA-3g25A:
undetectable		 2akeA-3g25A:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2AZX_A_TRPA601_0
(TRYPTOPHANYL-TRNA
SYNTHETASE)		 3g25 GLYCEROL KINASE
(Staphylococcus
aureus) 		5 / 12 THR A 266
GLY A 265
GLY A 409
THR A 263
GLN A 245
 PO4  A 502 ( 3.4A)
PO4  A 502 (-3.3A)
None
None
GOL  A 499 (-4.0A)
 1.27A 2azxA-3g25A:
undetectable		 2azxA-3g25A:
22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2AZX_B_TRPB603_0
(TRYPTOPHANYL-TRNA
SYNTHETASE)		 3g25 GLYCEROL KINASE
(Staphylococcus
aureus) 		5 / 12 THR A 266
GLY A 265
GLY A 409
THR A 263
GLN A 245
 PO4  A 502 ( 3.4A)
PO4  A 502 (-3.3A)
None
None
GOL  A 499 (-4.0A)
 1.23A 2azxB-3g25A:
undetectable		 2azxB-3g25A:
22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BR4_D_SAMD301_0
(CEPHALOSPORIN
HYDROXYLASE CMCI)		 1k4q GLUTATHIONE
REDUCTASE
(Homo
sapiens) 		5 / 12 LEU A 298
GLU A  50
GLY A  27
SER A  51
ALA A 155
 None
FAD  A 499 (-2.8A)
FAD  A 499 (-3.3A)
FAD  A 499 (-3.1A)
FAD  A 499 (-4.5A)
 1.08A 2br4D-1k4qA:
2.8		 2br4D-1k4qA:
18.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CML_A_ZMRA1477_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.75A 2cmlA-3silA:
13.2		 2cmlA-3silA:
22.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CML_B_ZMRB2477_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.75A 2cmlB-3silA:
19.8		 2cmlB-3silA:
22.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CML_C_ZMRC3477_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.77A 2cmlC-3silA:
7.4		 2cmlC-3silA:
22.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CML_D_ZMRD4477_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.77A 2cmlD-3silA:
19.7		 2cmlD-3silA:
22.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2F0Z_A_ZMRA381_1
(SIALIDASE 2)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ARG A  56
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
None
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.82A 2f0zA-3silA:
37.3		 2f0zA-3silA:
24.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2F0Z_A_ZMRA381_1
(SIALIDASE 2)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
MET A  99
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 (-3.5A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.54A 2f0zA-3silA:
37.3		 2f0zA-3silA:
24.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2F10_A_BCZA382_0
(SIALIDASE 2)		 3sil SIALIDASE
(Salmonella
enterica) 		8 / 12 ARG A  37
ILE A  38
ARG A  56
MET A  99
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
None
None
GOL  A 403 (-3.5A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.63A 2f10A-3silA:
36.3		 2f10A-3silA:
24.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FK8_A_SAMA302_0
(METHOXY MYCOLIC ACID
SYNTHASE 4)		 3sqg METHYL-COENZYME M
REDUCTASE, BETA
SUBUNIT
(uncultured
archaeon) 		5 / 12 GLY B 346
GLY B 383
GLU B 214
ALA B 351
HIS B 380
 None
None
None
None
MHO  A 499 ( 4.6A)
 0.96A 2fk8A-3sqgB:
undetectable		 2fk8A-3sqgB:
18.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2GQG_A_1N1A501_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		12 / 12 LEU A 251
ALA A 271
LYS A 273
GLU A 288
MET A 292
VAL A 301
ILE A 314
THR A 316
PHE A 318
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.51A 2gqgA-2hk5A:
30.6		 2gqgA-2hk5A:
47.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2GQG_B_1N1B502_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		11 / 12 LEU A 251
VAL A 259
ALA A 271
GLU A 288
MET A 292
VAL A 301
ILE A 314
THR A 316
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.50A 2gqgB-2hk5A:
36.8		 2gqgB-2hk5A:
47.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2GQG_B_1N1B502_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 LEU A 251
VAL A 259
ALA A 271
LYS A 273
GLU A 288
MET A 292
ILE A 314
THR A 316
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
 0.51A 2gqgB-2hk5A:
36.8		 2gqgB-2hk5A:
47.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HTQ_A_ZMRA472_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		5 / 12 ARG A  37
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.74A 2htqA-3silA:
11.9		 2htqA-3silA:
23.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HYY_A_STIA600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 ALA A 271
MET A 292
THR A 316
PHE A 318
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.66A 2hyyA-2hk5A:
27.6		 2hyyA-2hk5A:
47.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HYY_A_STIA600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 VAL A 259
ALA A 271
GLU A 288
MET A 292
THR A 316
PHE A 318
ASP A 382
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
 0.98A 2hyyA-2hk5A:
27.6		 2hyyA-2hk5A:
47.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HYY_A_STIA600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 VAL A 259
ALA A 271
MET A 292
THR A 316
PHE A 318
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.98A 2hyyA-2hk5A:
27.6		 2hyyA-2hk5A:
47.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HYY_A_STIA600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 6 LEU A 251
LYS A 273
VAL A 291
VAL A 301
ILE A 314
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.8A)
None
None
1BM  A 499 (-3.9A)
 0.80A 2hyyA-2hk5A:
27.6		 2hyyA-2hk5A:
47.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HYY_B_STIB600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 ALA A 271
MET A 292
THR A 316
PHE A 318
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.68A 2hyyB-2hk5A:
27.5		 2hyyB-2hk5A:
47.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HYY_B_STIB600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 VAL A 259
ALA A 271
GLU A 288
MET A 292
THR A 316
PHE A 318
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
 0.50A 2hyyB-2hk5A:
27.5		 2hyyB-2hk5A:
47.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HYY_B_STIB600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 VAL A 259
ALA A 271
MET A 292
THR A 316
PHE A 318
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.96A 2hyyB-2hk5A:
27.5		 2hyyB-2hk5A:
47.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HYY_B_STIB600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 6 LEU A 251
LYS A 273
VAL A 291
VAL A 301
ILE A 314
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.8A)
None
None
1BM  A 499 (-3.9A)
 0.64A 2hyyB-2hk5A:
27.5		 2hyyB-2hk5A:
47.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HYY_B_STIB600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 6 LEU A 251
VAL A 291
ILE A 314
MET A 319
 1BM  A 499 ( 3.7A)
None
1BM  A 499 (-3.9A)
None
 0.74A 2hyyB-2hk5A:
27.5		 2hyyB-2hk5A:
47.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HYY_C_STIC600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 VAL A 259
ALA A 271
GLU A 288
VAL A 301
THR A 316
PHE A 318
ASP A 382
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
 0.89A 2hyyC-2hk5A:
27.8		 2hyyC-2hk5A:
47.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HYY_C_STIC600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 VAL A 259
ALA A 271
VAL A 301
THR A 316
PHE A 318
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.72A 2hyyC-2hk5A:
27.8		 2hyyC-2hk5A:
47.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HYY_C_STIC600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 VAL A 259
ALA A 271
VAL A 301
THR A 316
PHE A 318
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.80A 2hyyC-2hk5A:
27.8		 2hyyC-2hk5A:
47.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HYY_C_STIC600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 6 LEU A 251
LYS A 273
VAL A 291
MET A 292
ILE A 314
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.8A)
None
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.9A)
 0.61A 2hyyC-2hk5A:
27.8		 2hyyC-2hk5A:
47.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HYY_C_STIC600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 6 LEU A 251
VAL A 291
MET A 292
ILE A 314
MET A 319
 1BM  A 499 ( 3.7A)
None
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.9A)
None
 0.65A 2hyyC-2hk5A:
27.8		 2hyyC-2hk5A:
47.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HYY_D_STID600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 VAL A 259
ALA A 271
GLU A 288
MET A 292
ILE A 314
THR A 316
PHE A 318
ALA A 381
ASP A 382
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.95A 2hyyD-2hk5A:
27.4		 2hyyD-2hk5A:
47.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HYY_D_STID600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 VAL A 259
ALA A 271
MET A 292
ILE A 314
THR A 316
PHE A 318
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.91A 2hyyD-2hk5A:
27.4		 2hyyD-2hk5A:
47.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HYY_D_STID600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 4 LEU A 251
LYS A 273
VAL A 301
MET A 319
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.8A)
None
None
 0.80A 2hyyD-2hk5A:
27.5		 2hyyD-2hk5A:
47.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ITO_A_IREA2020_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 LEU A 251
ALA A 271
LYS A 273
GLU A 288
MET A 292
THR A 316
GLY A 322
ASP A 326
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
None
1BM  A 499 (-4.4A)
 0.68A 2itoA-2hk5A:
32.2		 2itoA-2hk5A:
33.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ITY_A_IREA2020_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		10 / 12 LEU A 251
GLY A 252
VAL A 259
ALA A 271
LYS A 273
GLU A 288
MET A 292
THR A 316
GLY A 322
ASP A 382
 1BM  A 499 ( 3.7A)
None
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.72A 2ityA-2hk5A:
26.4		 2ityA-2hk5A:
33.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ITY_A_IREA2020_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		10 / 12 LEU A 251
GLY A 252
VAL A 259
ALA A 271
LYS A 273
GLU A 288
MET A 292
THR A 316
GLY A 322
LEU A 371
 1BM  A 499 ( 3.7A)
None
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.64A 2ityA-2hk5A:
26.4		 2ityA-2hk5A:
33.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ITZ_A_IREA2021_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		10 / 12 LEU A 251
VAL A 259
ALA A 271
LYS A 273
GLU A 288
MET A 292
THR A 316
GLY A 322
ASP A 326
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
None
1BM  A 499 (-4.4A)
 0.62A 2itzA-2hk5A:
26.3		 2itzA-2hk5A:
33.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2NO6_A_ETVA302_1
(DEOXYCYTIDINE KINASE)		 3snx PUTATIVE SUSD-LIKE
CARBOHYDRATE BINDING
PROTEIN
(Bacteroides
thetaiotaomicron) 		5 / 12 GLU A 355
LEU A 151
ARG A 408
ASP A 421
TYR A  69
 None
None
None
None
EDO  A 499 (-4.5A)
 1.32A 2no6A-3snxA:
0.7		 2no6A-3snxA:
21.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2NO6_A_ETVA302_1
(DEOXYCYTIDINE KINASE)		 3snx PUTATIVE SUSD-LIKE
CARBOHYDRATE BINDING
PROTEIN
(Bacteroides
thetaiotaomicron) 		5 / 12 GLU A 355
LEU A 229
GLN A 155
ARG A 408
TYR A  69
 None
None
None
None
EDO  A 499 (-4.5A)
 1.08A 2no6A-3snxA:
0.7		 2no6A-3snxA:
21.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2NYR_B_SVRB401_2
(NAD-DEPENDENT
DEACETYLASE
SIRTUIN-5)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 6 PHE A 402
ASN A 369
ASN A 290
LEU A 303
 None
1BM  A 499 (-4.1A)
None
None
 1.24A 2nyrA-2hk5A:
undetectable		 2nyrA-2hk5A:
19.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2NYU_B_SAMB201_0
(PUTATIVE RIBOSOMAL
RNA
METHYLTRANSFERASE 2)		 1k4q GLUTATHIONE
REDUCTASE
(Homo
sapiens) 		5 / 12 GLY A  28
ALA A 155
GLY A 157
LEU A 153
LEU A 118
 FAD  A 499 ( 4.7A)
FAD  A 499 (-4.5A)
FAD  A 499 (-3.4A)
None
NIY  A 114 ( 3.9A)
 1.04A 2nyuB-1k4qA:
3.2		 2nyuB-1k4qA:
19.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2OIQ_A_STIA1001_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		10 / 12 VAL A 259
ALA A 271
GLU A 288
MET A 292
ILE A 314
THR A 316
GLY A 322
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.96A 2oiqA-2hk5A:
28.1		 2oiqA-2hk5A:
67.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2OIQ_A_STIA1001_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 VAL A 259
ALA A 271
LYS A 273
GLU A 288
MET A 292
ILE A 314
THR A 316
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
 0.42A 2oiqA-2hk5A:
28.1		 2oiqA-2hk5A:
67.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2OIQ_A_STIA1001_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 5 LEU A 251
VAL A 291
LEU A 295
MET A 319
 1BM  A 499 ( 3.7A)
None
None
None
 0.71A 2oiqA-2hk5A:
28.1		 2oiqA-2hk5A:
67.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PL0_A_STIA200_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE LCK)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 ALA A 271
MET A 292
VAL A 301
ILE A 314
THR A 316
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.84A 2pl0A-2hk5A:
28.0		 2pl0A-2hk5A:
73.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PL0_A_STIA200_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE LCK)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 VAL A 259
ALA A 271
GLU A 288
MET A 292
VAL A 301
ILE A 314
THR A 316
ALA A 381
ASP A 382
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.93A 2pl0A-2hk5A:
28.0		 2pl0A-2hk5A:
73.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PL0_A_STIA200_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE LCK)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 VAL A 259
ALA A 271
LYS A 273
GLU A 288
MET A 292
VAL A 301
ILE A 314
THR A 316
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
 0.64A 2pl0A-2hk5A:
28.0		 2pl0A-2hk5A:
73.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q6F_C_010C6_0
(INFECTIOUS
BRONCHITIS VIRUS
(IBV) MAIN PROTEASE
N-[(5-METHYLISOXAZOL
-3-YL)CARBONYL]ALANY
L-L-VALYL-N~1~-((1R,
2Z)-4-(BENZYLOXY)-4-
OXO-1-{[(3R)-2-OXOPY
RROLIDIN-3-YL]METHYL
}BUT-2-ENYL)-L-LEUCI
NAMIDE)		 1k4q GLUTATHIONE
REDUCTASE
(Homo
sapiens) 		3 / 3 ASN A 294
LEU A 298
HIS A 129
 FAD  A 499 ( 4.5A)
None
FAD  A 499 (-3.4A)
 0.84A 2q6fB-1k4qA:
0.0		 2q6fB-1k4qA:
22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q6H_A_CXXA802_1
(TRANSPORTER)		 3ksc LEGA CLASS
(Pisum
sativum) 		4 / 7 ILE A 326
ARG A 323
ILE A  70
PHE A 435
 None
GOL  A 499 (-3.3A)
None
None
 1.05A 2q6hA-3kscA:
undetectable		 2q6hA-3kscA:
22.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q72_A_IXXA802_1
(TRANSPORTER)		 3ksc LEGA CLASS
(Pisum
sativum) 		4 / 6 ILE A 326
ARG A 323
ILE A  70
PHE A 435
 None
GOL  A 499 (-3.3A)
None
None
 1.06A 2q72A-3kscA:
undetectable		 2q72A-3kscA:
22.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QB4_A_DSMA802_1
(TRANSPORTER)		 3ksc LEGA CLASS
(Pisum
sativum) 		4 / 7 ILE A 326
ARG A 323
ILE A  70
PHE A 435
 None
GOL  A 499 (-3.3A)
None
None
 1.04A 2qb4A-3kscA:
undetectable		 2qb4A-3kscA:
22.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W8Y_A_486A1000_1
(PROGESTERONE
RECEPTOR)		 3pop GILR OXIDASE
(Streptomyces
griseoflavus) 		5 / 12 LEU A 153
LEU A 148
GLY A 138
PHE A 184
VAL A 128
 None
None
FAD  A 499 (-3.5A)
None
FAD  A 499 (-4.1A)
 1.23A 2w8yA-3popA:
undetectable		 2w8yA-3popA:
19.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2WGJ_A_VGHA2346_1
(HEPATOCYTE GROWTH
FACTOR RECEPTOR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 GLY A 252
VAL A 259
ALA A 271
MET A 319
GLY A 322
ALA A 381
 None
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
None
1BM  A 499 (-3.5A)
1BM  A 499 ( 3.7A)
 0.75A 2wgjA-2hk5A:
31.1		 2wgjA-2hk5A:
34.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2WGJ_A_VGHA2346_1
(HEPATOCYTE GROWTH
FACTOR RECEPTOR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 VAL A 259
ALA A 271
MET A 319
GLY A 322
ALA A 381
ASP A 382
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
None
1BM  A 499 (-3.5A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.72A 2wgjA-2hk5A:
31.1		 2wgjA-2hk5A:
34.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2XFF_A_QPSA600_1
(BETA-AMYLASE)		 1btc BETA-AMYLASE
(Glycine
max) 		10 / 12 ALA A 184
GLU A 186
ARG A 188
TYR A 192
GLN A 194
TRP A 198
SER A 297
GLY A 298
HIS A 300
MET A 346
 BME  A 502 ( 3.9A)
None
None
None
GLC  A 499 ( 4.0A)
None
None
BME  A 504 ( 4.3A)
GLC  A 499 ( 4.0A)
GLC  A 499 (-3.7A)
 0.67A 2xffA-1btcA:
61.8		 2xffA-1btcA:
62.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2XFF_A_QPSA600_1
(BETA-AMYLASE)		 1btc BETA-AMYLASE
(Glycine
max) 		10 / 12 ALA A 184
GLU A 186
ARG A 188
TYR A 192
TRP A 198
PHE A 200
SER A 297
GLY A 298
HIS A 300
MET A 346
 BME  A 502 ( 3.9A)
None
None
None
None
GLC  A 499 ( 3.6A)
None
BME  A 504 ( 4.3A)
GLC  A 499 ( 4.0A)
GLC  A 499 (-3.7A)
 0.50A 2xffA-1btcA:
61.8		 2xffA-1btcA:
62.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2XFF_A_QPSA600_1
(BETA-AMYLASE)		 1btc BETA-AMYLASE
(Glycine
max) 		6 / 12 TYR A 192
GLN A 194
TRP A 198
SER A 297
GLY A 298
THR A 342
 None
GLC  A 499 ( 4.0A)
None
None
BME  A 504 ( 4.3A)
None
 1.10A 2xffA-1btcA:
61.8		 2xffA-1btcA:
62.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XNR_A_ACTA1001_0
(NUCLEAR
POLYADENYLATED
RNA-BINDING PROTEIN
3)		 1cc1 HYDROGENASE (LARGE
SUBUNIT)
(Desulfomicrobium
baculatum) 		3 / 3 SER L 112
ARG L 172
GLN L 111
 FCO  L 499 ( 4.8A)
None
None
 0.76A 2xnrA-1cc1L:
0.0		 2xnrA-1cc1L:
12.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2XP2_A_VGHA9000_1
(TYROSINE-PROTEIN
KINASE RECEPTOR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 9 LEU A 251
VAL A 259
ALA A 271
MET A 319
GLY A 322
LEU A 371
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 (-4.4A)
 0.49A 2xp2A-2hk5A:
32.0		 2xp2A-2hk5A:
36.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Y6O_A_1N1A1892_1
(EPHRIN TYPE-A
RECEPTOR 4)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 ALA A 271
LYS A 273
GLU A 288
MET A 292
ILE A 314
THR A 316
GLY A 322
LEU A 371
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.44A 2y6oA-2hk5A:
28.1		 2y6oA-2hk5A:
42.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y6R_B_CTCB1385_0
(TETX2 PROTEIN)		 4y85 MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 8
(Homo
sapiens) 		4 / 8 MET A 207
GLY A 210
PRO A 145
GLY A 147
 499  A 401 ( 3.7A)
499  A 401 (-3.4A)
499  A 401 (-4.2A)
499  A 401 (-3.3A)
 0.77A 2y6rB-4y85A:
undetectable		 2y6rB-4y85A:
21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7J_C_B49C1294_1
(PHOSPHORYLASE B
KINASE GAMMA
CATALYTIC CHAIN,
TESTIS/LIVER ISOFORM)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 10 VAL A 259
ALA A 271
MET A 319
GLY A 322
ASP A 326
LEU A 371
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
None
1BM  A 499 (-3.5A)
None
1BM  A 499 (-4.4A)
 0.47A 2y7jC-2hk5A:
20.8		 2y7jC-2hk5A:
23.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7J_D_B49D1294_1
(PHOSPHORYLASE B
KINASE GAMMA
CATALYTIC CHAIN,
TESTIS/LIVER ISOFORM)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 10 VAL A 259
ALA A 271
MET A 319
GLY A 322
ASP A 326
LEU A 371
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
None
1BM  A 499 (-3.5A)
None
1BM  A 499 (-4.4A)
 0.32A 2y7jD-2hk5A:
21.2		 2y7jD-2hk5A:
23.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YA7_A_ZMRA1776_1
(NEURAMINIDASE A)		 3sil SIALIDASE
(Salmonella
enterica) 		7 / 12 ARG A  37
ILE A  38
ASP A  54
ASP A 100
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
None
None
GOL  A 403 (-3.4A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.43A 2ya7A-3silA:
40.4		 2ya7A-3silA:
25.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YA7_B_ZMRB1776_1
(NEURAMINIDASE A)		 3sil SIALIDASE
(Salmonella
enterica) 		7 / 12 ARG A  37
ILE A  38
ASP A  54
ASP A 100
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
None
None
GOL  A 403 (-3.4A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.44A 2ya7B-3silA:
40.0		 2ya7B-3silA:
25.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YA7_C_ZMRC1776_1
(NEURAMINIDASE A)		 3sil SIALIDASE
(Salmonella
enterica) 		7 / 12 ARG A  37
ILE A  38
ASP A  54
ASP A 100
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
None
None
GOL  A 403 (-3.4A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.41A 2ya7C-3silA:
36.7		 2ya7C-3silA:
25.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YA7_C_ZMRC1776_1
(NEURAMINIDASE A)		 3sil SIALIDASE
(Salmonella
enterica) 		7 / 12 ILE A  38
ASP A  54
ASP A 100
LEU A 205
ARG A 246
ARG A 309
TYR A 342
 None
None
GOL  A 403 (-3.4A)
None
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 1.39A 2ya7C-3silA:
36.7		 2ya7C-3silA:
25.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YA7_D_ZMRD1776_1
(NEURAMINIDASE A)		 3sil SIALIDASE
(Salmonella
enterica) 		7 / 12 ARG A  37
ILE A  38
ASP A  54
ASP A 100
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
None
None
GOL  A 403 (-3.4A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.43A 2ya7D-3silA:
39.8		 2ya7D-3silA:
25.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YFX_A_VGHA9000_1
(TYROSINE-PROTEIN
KINASE RECEPTOR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 8 LEU A 251
ALA A 271
MET A 319
GLY A 322
LEU A 371
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 (-4.4A)
 0.48A 2yfxA-2hk5A:
24.7		 2yfxA-2hk5A:
36.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ZVA_A_1N1A513_1
(TYROSINE-PROTEIN
KINASE LYN)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		12 / 12 LEU A 251
ALA A 271
LYS A 273
GLU A 288
MET A 292
VAL A 301
ILE A 314
THR A 316
MET A 319
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.41A 2zvaA-2hk5A:
31.0		 2zvaA-2hk5A:
80.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZW9_A_SAMA801_0
(LEUCINE CARBOXYL
METHYLTRANSFERASE 2)		 3snx PUTATIVE SUSD-LIKE
CARBOHYDRATE BINDING
PROTEIN
(Bacteroides
thetaiotaomicron) 		5 / 12 GLN A  75
GLY A 416
GLY A 418
ASP A 421
ASN A 290
 None
EDO  A 499 (-4.2A)
None
None
None
 1.14A 2zw9A-3snxA:
undetectable		 2zw9A-3snxA:
20.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ABK_C_CHDC525_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 3)		 5mc5 XAA-PRO DIPEPTIDASE
(Homo
sapiens) 		4 / 7 HIS A 377
ASP A 453
THR A 410
HIS A 255
 GLY  A 503 ( 3.9A)
None
MN  A 499 ( 4.0A)
PRO  A 504 (-4.2A)
 1.38A 3abkA-5mc5A:
undetectable
3abkC-5mc5A:
undetectable		 3abkA-5mc5A:
undetectable
3abkC-5mc5A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AG2_A_CHDA525_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 3)		 5mc5 XAA-PRO DIPEPTIDASE
(Homo
sapiens) 		4 / 7 HIS A 377
ASP A 453
THR A 410
HIS A 255
 GLY  A 503 ( 3.9A)
None
MN  A 499 ( 4.0A)
PRO  A 504 (-4.2A)
 1.39A 3ag2A-5mc5A:
undetectable
3ag2C-5mc5A:
2.3		 3ag2A-5mc5A:
undetectable
3ag2C-5mc5A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AG4_C_CHDC525_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 3)		 5mc5 XAA-PRO DIPEPTIDASE
(Homo
sapiens) 		4 / 7 HIS A 377
ASP A 453
THR A 410
HIS A 255
 GLY  A 503 ( 3.9A)
None
MN  A 499 ( 4.0A)
PRO  A 504 (-4.2A)
 1.40A 3ag4A-5mc5A:
undetectable
3ag4C-5mc5A:
undetectable		 3ag4A-5mc5A:
undetectable
3ag4C-5mc5A:
undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3AOX_A_EMHA901_1
(ALK TYROSINE KINASE
RECEPTOR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 10 LEU A 251
ALA A 271
LYS A 273
VAL A 301
MET A 319
GLY A 322
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
None
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.59A 3aoxA-2hk5A:
30.8		 3aoxA-2hk5A:
33.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3B7E_A_ZMRA1001_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.82A 3b7eA-3silA:
20.1		 3b7eA-3silA:
23.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3B7E_B_ZMRB1002_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.83A 3b7eB-3silA:
20.1		 3b7eB-3silA:
23.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3BBT_B_FMMB91_1
(RECEPTOR
TYROSINE-PROTEIN
KINASE ERBB-4)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 VAL A 259
ALA A 271
LEU A 303
THR A 316
GLY A 322
LEU A 371
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.59A 3bbtB-2hk5A:
24.1		 3bbtB-2hk5A:
34.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3C7Q_A_XINA1172_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 LEU A 251
GLY A 252
ALA A 271
LYS A 273
VAL A 301
PHE A 318
GLY A 322
LEU A 371
 1BM  A 499 ( 3.7A)
None
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
None
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.83A 3c7qA-2hk5A:
23.9		 3c7qA-2hk5A:
39.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CKZ_A_ZMRA469_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		5 / 12 ARG A  37
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.51A 3ckzA-3silA:
20.3		 3ckzA-3silA:
22.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CS9_A_NILA600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 10 LEU A 251
VAL A 259
LYS A 273
VAL A 301
ILE A 314
PHE A 318
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-4.1A)
 0.64A 3cs9A-2hk5A:
27.5		 3cs9A-2hk5A:
48.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CS9_A_NILA600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 10 LEU A 251
VAL A 259
VAL A 301
ILE A 314
PHE A 318
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
 0.76A 3cs9A-2hk5A:
27.5		 3cs9A-2hk5A:
48.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CS9_A_NILA600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 ALA A 271
GLU A 288
VAL A 291
MET A 292
LEU A 300
THR A 316
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
None
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
 0.57A 3cs9A-2hk5A:
27.5		 3cs9A-2hk5A:
48.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CS9_A_NILA600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 ALA A 271
VAL A 291
MET A 292
LEU A 300
THR A 316
GLY A 322
HIS A 362
LEU A 371
ALA A 381
 1BM  A 499 (-3.6A)
None
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
None
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.64A 3cs9A-2hk5A:
27.5		 3cs9A-2hk5A:
48.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CS9_B_NILB600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 ALA A 271
GLU A 288
VAL A 291
MET A 292
LEU A 300
THR A 316
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
None
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
 0.51A 3cs9B-2hk5A:
28.0		 3cs9B-2hk5A:
48.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CS9_B_NILB600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 ALA A 271
VAL A 291
MET A 292
LEU A 300
THR A 316
GLY A 322
HIS A 362
ALA A 381
 1BM  A 499 (-3.6A)
None
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
None
1BM  A 499 ( 3.7A)
 0.57A 3cs9B-2hk5A:
28.0		 3cs9B-2hk5A:
48.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CS9_B_NILB600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 9 LEU A 251
VAL A 259
LYS A 273
VAL A 301
ILE A 314
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.8A)
None
1BM  A 499 (-3.9A)
 0.69A 3cs9B-2hk5A:
28.0		 3cs9B-2hk5A:
48.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CS9_B_NILB600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 9 LEU A 251
VAL A 259
VAL A 301
ILE A 314
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-4.4A)
 0.80A 3cs9B-2hk5A:
28.0		 3cs9B-2hk5A:
48.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CS9_C_NILC600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 ALA A 271
GLU A 288
VAL A 291
MET A 292
LEU A 300
THR A 316
PHE A 318
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
None
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
 0.56A 3cs9C-2hk5A:
27.7		 3cs9C-2hk5A:
48.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CS9_C_NILC600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 ALA A 271
VAL A 291
MET A 292
LEU A 300
THR A 316
PHE A 318
HIS A 362
ALA A 381
 1BM  A 499 (-3.6A)
None
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
None
1BM  A 499 ( 3.7A)
 0.78A 3cs9C-2hk5A:
27.7		 3cs9C-2hk5A:
48.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CS9_C_NILC600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 ALA A 271
VAL A 291
MET A 292
THR A 316
PHE A 318
ALA A 381
ASP A 382
 1BM  A 499 (-3.6A)
None
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.84A 3cs9C-2hk5A:
27.7		 3cs9C-2hk5A:
48.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CS9_C_NILC600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 9 LEU A 251
VAL A 259
LYS A 273
VAL A 301
ILE A 314
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.8A)
None
1BM  A 499 (-3.9A)
 0.62A 3cs9C-2hk5A:
27.7		 3cs9C-2hk5A:
48.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CS9_C_NILC600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 9 LEU A 251
VAL A 259
VAL A 301
ILE A 314
MET A 319
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
None
1BM  A 499 (-3.9A)
None
 0.67A 3cs9C-2hk5A:
27.7		 3cs9C-2hk5A:
48.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CS9_D_NILD600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 ALA A 271
GLU A 288
VAL A 291
MET A 292
LEU A 300
THR A 316
PHE A 318
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
None
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
 0.60A 3cs9D-2hk5A:
27.2		 3cs9D-2hk5A:
48.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CS9_D_NILD600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 ALA A 271
MET A 292
LEU A 300
THR A 316
PHE A 318
GLY A 322
HIS A 362
ALA A 381
 1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
None
1BM  A 499 ( 3.7A)
 0.66A 3cs9D-2hk5A:
27.2		 3cs9D-2hk5A:
48.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CS9_D_NILD600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 ALA A 271
VAL A 291
MET A 292
LEU A 300
THR A 316
PHE A 318
GLY A 322
ALA A 381
 1BM  A 499 (-3.6A)
None
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 ( 3.7A)
 0.71A 3cs9D-2hk5A:
27.2		 3cs9D-2hk5A:
48.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CSJ_B_CBLB211_0
(GLUTATHIONE
S-TRANSFERASE P)		 3pop GILR OXIDASE
(Streptomyces
griseoflavus) 		5 / 9 VAL A 150
GLY A 189
ILE A 446
TYR A 445
GLY A 138
 None
None
None
FAD  A 499 (-4.4A)
FAD  A 499 (-3.5A)
 1.25A 3csjB-3popA:
undetectable		 3csjB-3popA:
18.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G0E_A_B49A9000_1
(MAST/STEM CELL
GROWTH FACTOR
RECEPTOR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 11 LEU A 251
VAL A 259
ALA A 271
VAL A 301
THR A 316
GLY A 322
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.94A 3g0eA-2hk5A:
29.1		 3g0eA-2hk5A:
37.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G5D_A_1N1A1_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		11 / 12 LEU A 251
VAL A 259
ALA A 271
GLU A 288
MET A 292
VAL A 301
ILE A 314
THR A 316
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.50A 3g5dA-2hk5A:
29.5		 3g5dA-2hk5A:
66.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G5D_B_1N1B1_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		11 / 12 LEU A 251
VAL A 259
ALA A 271
LYS A 273
GLU A 288
MET A 292
VAL A 301
THR A 316
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.45A 3g5dB-2hk5A:
29.5		 3g5dB-2hk5A:
66.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3GCS_A_BAXA401_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 12 VAL A 259
ALA A 271
GLU A 288
THR A 316
ILE A 355
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.2A)
None
 0.80A 3gcsA-2hk5A:
17.7		 3gcsA-2hk5A:
24.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3GCS_A_BAXA401_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 12 VAL A 259
ALA A 271
THR A 316
ILE A 355
HIS A 362
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
None
None
 0.87A 3gcsA-2hk5A:
17.7		 3gcsA-2hk5A:
24.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GVU_A_STIA1001_1
(TYROSINE-PROTEIN
KINASE ABL2)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		10 / 12 LEU A 251
VAL A 259
ALA A 271
GLU A 288
MET A 292
VAL A 301
THR A 316
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.98A 3gvuA-2hk5A:
27.4		 3gvuA-2hk5A:
44.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GVU_A_STIA1001_2
(TYROSINE-PROTEIN
KINASE ABL2)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 5 LYS A 273
VAL A 291
ILE A 314
MET A 319
 1BM  A 499 (-3.8A)
None
1BM  A 499 (-3.9A)
None
 0.73A 3gvuA-2hk5A:
27.4		 3gvuA-2hk5A:
44.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HEG_A_BAXA1_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 VAL A 259
ALA A 271
LYS A 273
GLU A 288
THR A 316
ILE A 355
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.2A)
None
 0.78A 3hegA-2hk5A:
13.2		 3hegA-2hk5A:
25.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3IK3_A_0LIA1_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 ALA A 271
MET A 292
LEU A 300
VAL A 301
HIS A 362
LEU A 371
ALA A 381
 1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
None
None
None
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.76A 3ik3A-2hk5A:
27.2		 3ik3A-2hk5A:
46.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3IK3_A_0LIA1_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 ALA A 271
MET A 292
VAL A 301
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.90A 3ik3A-2hk5A:
27.2		 3ik3A-2hk5A:
46.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3IK3_A_0LIA1_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 7 LEU A 251
LYS A 273
VAL A 291
ILE A 314
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.8A)
None
1BM  A 499 (-3.9A)
 0.59A 3ik3A-2hk5A:
27.2		 3ik3A-2hk5A:
46.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3IK3_A_0LIA1_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 7 LEU A 251
VAL A 291
ILE A 314
MET A 319
 1BM  A 499 ( 3.7A)
None
1BM  A 499 (-3.9A)
None
 0.68A 3ik3A-2hk5A:
27.2		 3ik3A-2hk5A:
46.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3IK3_B_0LIB2_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 ALA A 271
MET A 292
LEU A 300
VAL A 301
HIS A 362
LEU A 371
ALA A 381
 1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
None
None
None
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.80A 3ik3B-2hk5A:
26.9		 3ik3B-2hk5A:
46.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3IK3_B_0LIB2_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 7 LEU A 251
LYS A 273
VAL A 291
ILE A 314
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.8A)
None
1BM  A 499 (-3.9A)
 0.58A 3ik3B-2hk5A:
26.8		 3ik3B-2hk5A:
46.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3IK3_B_0LIB2_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 7 LEU A 251
VAL A 291
ILE A 314
MET A 319
 1BM  A 499 ( 3.7A)
None
1BM  A 499 (-3.9A)
None
 0.72A 3ik3B-2hk5A:
26.8		 3ik3B-2hk5A:
46.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K13_A_THHA642_1
(5-METHYLTETRAHYDROFO
LATE-HOMOCYSTEINE
METHYLTRANSFERASE)		 3g25 GLYCEROL KINASE
(Staphylococcus
aureus) 		3 / 3 ASN A 184
ASP A 244
ARG A 105
 None
GOL  A 499 ( 2.8A)
None
 0.84A 3k13A-3g25A:
undetectable		 3k13A-3g25A:
21.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K37_B_BCZB468_0
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		5 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
 0.84A 3k37B-3silA:
23.5		 3k37B-3silA:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K39_B_BCZB1001_0
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		5 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-4.6A)
 0.64A 3k39B-3silA:
23.3		 3k39B-3silA:
21.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K54_A_1N1A1_1
(TYROSINE-PROTEIN
KINASE BTK)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		10 / 12 LEU A 251
ALA A 271
LYS A 273
GLU A 288
MET A 292
VAL A 301
ILE A 314
THR A 316
GLY A 322
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.51A 3k54A-2hk5A:
32.3		 3k54A-2hk5A:
39.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K5V_A_STIA2_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 ALA A 271
GLU A 288
MET A 292
THR A 316
PHE A 318
GLY A 322
ALA A 381
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 ( 3.7A)
 0.86A 3k5vA-2hk5A:
31.8		 3k5vA-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K5V_A_STIA2_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 ALA A 271
MET A 292
THR A 316
PHE A 318
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.74A 3k5vA-2hk5A:
31.8		 3k5vA-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K5V_A_STIA2_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 VAL A 259
ALA A 271
GLU A 288
MET A 292
THR A 316
PHE A 318
ALA A 381
ASP A 382
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 1.00A 3k5vA-2hk5A:
31.8		 3k5vA-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K5V_A_STIA2_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 VAL A 259
ALA A 271
MET A 292
THR A 316
PHE A 318
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 1.00A 3k5vA-2hk5A:
31.8		 3k5vA-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K5V_A_STIA2_2
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 6 LEU A 251
LYS A 273
VAL A 291
VAL A 301
ILE A 314
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.8A)
None
None
1BM  A 499 (-3.9A)
 0.61A 3k5vA-2hk5A:
31.7		 3k5vA-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K5V_A_STIA2_2
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 6 LEU A 251
VAL A 291
ILE A 314
MET A 319
 1BM  A 499 ( 3.7A)
None
1BM  A 499 (-3.9A)
None
 0.76A 3k5vA-2hk5A:
31.7		 3k5vA-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K5V_B_STIB2_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 ALA A 271
GLU A 288
MET A 292
THR A 316
PHE A 318
GLY A 322
ALA A 381
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 ( 3.7A)
 0.83A 3k5vB-2hk5A:
26.6		 3k5vB-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K5V_B_STIB2_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 ALA A 271
MET A 292
THR A 316
PHE A 318
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.71A 3k5vB-2hk5A:
26.6		 3k5vB-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K5V_B_STIB2_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 VAL A 259
ALA A 271
GLU A 288
MET A 292
THR A 316
PHE A 318
ALA A 381
ASP A 382
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.98A 3k5vB-2hk5A:
26.6		 3k5vB-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K5V_B_STIB2_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 VAL A 259
ALA A 271
MET A 292
THR A 316
PHE A 318
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.98A 3k5vB-2hk5A:
26.6		 3k5vB-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K5V_B_STIB2_2
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 6 LEU A 251
LYS A 273
VAL A 301
ILE A 314
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.8A)
None
1BM  A 499 (-3.9A)
 0.70A 3k5vB-2hk5A:
26.6		 3k5vB-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K5V_B_STIB2_2
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 6 LEU A 251
VAL A 301
ILE A 314
MET A 319
 1BM  A 499 ( 3.7A)
None
1BM  A 499 (-3.9A)
None
 0.70A 3k5vB-2hk5A:
26.6		 3k5vB-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K5V_B_STIB2_2
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 6 LYS A 273
VAL A 291
VAL A 301
ILE A 314
 1BM  A 499 (-3.8A)
None
None
1BM  A 499 (-3.9A)
 0.59A 3k5vB-2hk5A:
26.6		 3k5vB-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K5V_B_STIB2_2
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 6 VAL A 291
VAL A 301
ILE A 314
MET A 319
 None
None
1BM  A 499 (-3.9A)
None
 0.59A 3k5vB-2hk5A:
26.6		 3k5vB-2hk5A:
46.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LFA_A_1N1A361_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 8 ALA A 271
LYS A 273
GLU A 288
THR A 316
MET A 319
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.2A)
None
 0.70A 3lfaA-2hk5A:
20.4		 3lfaA-2hk5A:
24.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MIY_A_B49A1_1
(TYROSINE-PROTEIN
KINASE ITK/TSK)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 11 ALA A 271
LYS A 273
VAL A 301
PHE A 318
MET A 319
GLY A 322
LEU A 371
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
None
1BM  A 499 (-4.1A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.58A 3miyA-2hk5A:
26.0		 3miyA-2hk5A:
39.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MIY_B_B49B2_1
(TYROSINE-PROTEIN
KINASE ITK/TSK)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 9 ALA A 271
LYS A 273
PHE A 318
MET A 319
GLY A 322
LEU A 371
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-4.1A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.58A 3miyB-2hk5A:
32.7		 3miyB-2hk5A:
39.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MS9_A_STIA1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 LEU A 251
VAL A 259
ALA A 271
GLU A 288
MET A 292
THR A 316
PHE A 318
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
 0.91A 3ms9A-2hk5A:
27.5		 3ms9A-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MS9_A_STIA1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 LEU A 251
VAL A 259
ALA A 271
MET A 292
THR A 316
PHE A 318
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.96A 3ms9A-2hk5A:
27.5		 3ms9A-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MS9_A_STIA1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 6 LYS A 273
VAL A 291
VAL A 301
ILE A 314
 1BM  A 499 (-3.8A)
None
None
1BM  A 499 (-3.9A)
 0.60A 3ms9A-2hk5A:
27.5		 3ms9A-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MS9_A_STIA1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 6 VAL A 291
VAL A 301
ILE A 314
MET A 319
 None
None
1BM  A 499 (-3.9A)
None
 0.60A 3ms9A-2hk5A:
27.5		 3ms9A-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MS9_B_STIB1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 LEU A 251
ALA A 271
MET A 292
THR A 316
PHE A 318
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.90A 3ms9B-2hk5A:
27.6		 3ms9B-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MS9_B_STIB1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 LEU A 251
VAL A 259
ALA A 271
GLU A 288
MET A 292
THR A 316
PHE A 318
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
 0.96A 3ms9B-2hk5A:
27.6		 3ms9B-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MS9_B_STIB1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 LEU A 251
VAL A 259
ALA A 271
MET A 292
THR A 316
PHE A 318
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 1.01A 3ms9B-2hk5A:
27.6		 3ms9B-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MS9_B_STIB1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 7 LYS A 273
VAL A 291
VAL A 301
ILE A 314
 1BM  A 499 (-3.8A)
None
None
1BM  A 499 (-3.9A)
 0.61A 3ms9B-2hk5A:
27.6		 3ms9B-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MS9_B_STIB1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 7 VAL A 291
VAL A 301
ILE A 314
MET A 319
 None
None
1BM  A 499 (-3.9A)
None
 0.60A 3ms9B-2hk5A:
27.6		 3ms9B-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MSS_A_STIA1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 LEU A 251
VAL A 259
ALA A 271
GLU A 288
MET A 292
THR A 316
PHE A 318
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
 0.97A 3mssA-2hk5A:
27.6		 3mssA-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MSS_A_STIA1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 LEU A 251
VAL A 259
ALA A 271
MET A 292
THR A 316
PHE A 318
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 1.00A 3mssA-2hk5A:
27.6		 3mssA-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MSS_A_STIA1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 6 LYS A 273
VAL A 291
VAL A 301
ILE A 314
 1BM  A 499 (-3.8A)
None
None
1BM  A 499 (-3.9A)
 0.58A 3mssA-2hk5A:
27.6		 3mssA-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MSS_A_STIA1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 6 VAL A 291
VAL A 301
ILE A 314
MET A 319
 None
None
1BM  A 499 (-3.9A)
None
 0.61A 3mssA-2hk5A:
27.6		 3mssA-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MSS_B_STIB1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 ALA A 271
MET A 292
THR A 316
PHE A 318
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.74A 3mssB-2hk5A:
27.8		 3mssB-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MSS_B_STIB1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 VAL A 259
ALA A 271
GLU A 288
MET A 292
THR A 316
PHE A 318
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
 0.48A 3mssB-2hk5A:
27.8		 3mssB-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MSS_B_STIB1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 7 LYS A 273
VAL A 291
VAL A 301
ILE A 314
 1BM  A 499 (-3.8A)
None
None
1BM  A 499 (-3.9A)
 0.59A 3mssB-2hk5A:
27.8		 3mssB-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MSS_B_STIB1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 7 VAL A 291
VAL A 301
ILE A 314
MET A 319
ARG A 363
 None
None
1BM  A 499 (-3.9A)
None
None
 1.02A 3mssB-2hk5A:
27.8		 3mssB-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MSS_C_STIC1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 LEU A 251
VAL A 259
ALA A 271
GLU A 288
MET A 292
THR A 316
PHE A 318
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
 0.98A 3mssC-2hk5A:
27.5		 3mssC-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MSS_C_STIC1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 LEU A 251
VAL A 259
ALA A 271
MET A 292
THR A 316
PHE A 318
ALA A 381
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.94A 3mssC-2hk5A:
27.5		 3mssC-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MSS_C_STIC1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 LEU A 251
VAL A 259
ALA A 271
MET A 292
THR A 316
PHE A 318
LEU A 371
ALA A 381
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.96A 3mssC-2hk5A:
27.5		 3mssC-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MSS_C_STIC1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 6 LYS A 273
VAL A 291
VAL A 301
ILE A 314
 1BM  A 499 (-3.8A)
None
None
1BM  A 499 (-3.9A)
 0.61A 3mssC-2hk5A:
27.5		 3mssC-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MSS_C_STIC1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 6 VAL A 291
VAL A 301
ILE A 314
MET A 319
 None
None
1BM  A 499 (-3.9A)
None
 0.64A 3mssC-2hk5A:
27.5		 3mssC-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MSS_D_STID1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 LEU A 251
ALA A 271
GLU A 288
MET A 292
THR A 316
PHE A 318
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
 0.98A 3mssD-2hk5A:
27.8		 3mssD-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MSS_D_STID1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 LEU A 251
ALA A 271
MET A 292
THR A 316
PHE A 318
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.95A 3mssD-2hk5A:
27.8		 3mssD-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MSS_D_STID1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 LEU A 251
ALA A 271
MET A 292
THR A 316
PHE A 318
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 1.00A 3mssD-2hk5A:
27.8		 3mssD-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MSS_D_STID1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 6 VAL A 259
LYS A 273
VAL A 291
VAL A 301
ILE A 314
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.8A)
None
None
1BM  A 499 (-3.9A)
 0.60A 3mssD-2hk5A:
27.8		 3mssD-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MSS_D_STID1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 6 VAL A 259
VAL A 291
VAL A 301
ILE A 314
MET A 319
 1BM  A 499 ( 4.8A)
None
None
1BM  A 499 (-3.9A)
None
 0.76A 3mssD-2hk5A:
27.8		 3mssD-2hk5A:
46.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N23_C_OBNC1_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		 3ksc LEGA CLASS
(Pisum
sativum) 		5 / 11 ASP A 118
ASN A 325
LEU A 324
VAL A 345
ALA A 360
 None
None
GOL  A 499 ( 4.9A)
None
None
 1.27A 3n23C-3kscA:
undetectable		 3n23C-3kscA:
18.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OCT_A_1N1A663_1
(TYROSINE-PROTEIN
KINASE BTK)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		10 / 12 LEU A 251
VAL A 259
ALA A 271
LYS A 273
MET A 292
VAL A 301
THR A 316
GLY A 322
GLU A 332
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
None
1BM  A 499 (-4.4A)
 1.07A 3octA-2hk5A:
31.8		 3octA-2hk5A:
40.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OEZ_A_STIA601_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 ALA A 271
MET A 292
VAL A 301
THR A 316
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.61A 3oezA-2hk5A:
27.8		 3oezA-2hk5A:
66.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OEZ_A_STIA601_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 VAL A 259
ALA A 271
GLU A 288
MET A 292
VAL A 301
THR A 316
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
 0.48A 3oezA-2hk5A:
27.8		 3oezA-2hk5A:
66.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OEZ_A_STIA601_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 VAL A 259
ALA A 271
MET A 292
VAL A 301
THR A 316
LEU A 371
ALA A 381
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.72A 3oezA-2hk5A:
27.8		 3oezA-2hk5A:
66.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OEZ_B_STIB601_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 ALA A 271
GLU A 288
VAL A 291
MET A 292
ILE A 314
THR A 316
LEU A 371
ASP A 382
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
None
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.4A)
1BM  A 499 (-4.4A)
 0.92A 3oezB-2hk5A:
27.7		 3oezB-2hk5A:
66.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OEZ_B_STIB601_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 ALA A 271
VAL A 291
MET A 292
ILE A 314
THR A 316
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 (-3.6A)
None
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.91A 3oezB-2hk5A:
27.7		 3oezB-2hk5A:
66.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OEZ_B_STIB601_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 VAL A 259
ALA A 271
LYS A 273
GLU A 288
VAL A 291
MET A 292
ILE A 314
THR A 316
LEU A 371
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
None
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.4A)
 0.60A 3oezB-2hk5A:
27.7		 3oezB-2hk5A:
66.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OEZ_B_STIB601_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 VAL A 259
ALA A 271
LYS A 273
VAL A 291
MET A 292
ILE A 314
THR A 316
LEU A 371
ALA A 381
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
None
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.57A 3oezB-2hk5A:
27.7		 3oezB-2hk5A:
66.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OG7_A_032A1_1
(AKAP9-BRAF FUSION
PROTEIN)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 12 VAL A 259
ALA A 271
LYS A 273
THR A 316
PHE A 383
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
None
 0.65A 3og7A-2hk5A:
27.0		 3og7A-2hk5A:
31.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OHT_A_1N1A1000_1
(P38A)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 GLY A 252
VAL A 259
ALA A 271
LYS A 273
THR A 316
LEU A 371
 None
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.4A)
 0.82A 3ohtA-2hk5A:
17.0		 3ohtA-2hk5A:
24.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OHT_B_1N1B1000_1
(P38A)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 GLY A 252
VAL A 259
ALA A 271
LYS A 273
THR A 316
LEU A 371
 None
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.4A)
 0.84A 3ohtB-2hk5A:
17.1		 3ohtB-2hk5A:
24.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXZ_A_0LIA1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 ALA A 271
GLU A 288
MET A 292
LEU A 300
VAL A 301
THR A 316
GLY A 322
HIS A 362
ALA A 381
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
None
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
None
1BM  A 499 ( 3.7A)
 0.72A 3oxzA-2hk5A:
27.3		 3oxzA-2hk5A:
46.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXZ_A_0LIA1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 ALA A 271
GLU A 288
MET A 292
VAL A 301
THR A 316
GLY A 322
ALA A 381
ASP A 382
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.96A 3oxzA-2hk5A:
27.3		 3oxzA-2hk5A:
46.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXZ_A_0LIA1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 9 LEU A 251
LYS A 273
VAL A 291
ILE A 314
MET A 319
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.8A)
None
1BM  A 499 (-3.9A)
None
1BM  A 499 (-4.4A)
 0.76A 3oxzA-2hk5A:
27.3		 3oxzA-2hk5A:
46.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PYY_A_STIA3_1
(V-ABL ABELSON MURINE
LEUKEMIA VIRAL
ONCOGENE HOMOLOG 1
ISOFORM B VARIANT)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 ALA A 271
MET A 292
THR A 316
PHE A 318
ALA A 381
ASP A 382
 1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.75A 3pyyA-2hk5A:
27.6		 3pyyA-2hk5A:
45.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PYY_A_STIA3_1
(V-ABL ABELSON MURINE
LEUKEMIA VIRAL
ONCOGENE HOMOLOG 1
ISOFORM B VARIANT)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 ALA A 271
MET A 292
THR A 316
PHE A 318
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.76A 3pyyA-2hk5A:
27.6		 3pyyA-2hk5A:
45.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PYY_A_STIA3_1
(V-ABL ABELSON MURINE
LEUKEMIA VIRAL
ONCOGENE HOMOLOG 1
ISOFORM B VARIANT)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 VAL A 259
ALA A 271
GLU A 288
MET A 292
THR A 316
PHE A 318
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
 0.41A 3pyyA-2hk5A:
27.6		 3pyyA-2hk5A:
45.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PYY_A_STIA3_1
(V-ABL ABELSON MURINE
LEUKEMIA VIRAL
ONCOGENE HOMOLOG 1
ISOFORM B VARIANT)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 VAL A 259
ALA A 271
MET A 292
THR A 316
PHE A 318
ALA A 381
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 ( 3.7A)
 0.80A 3pyyA-2hk5A:
27.6		 3pyyA-2hk5A:
45.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PYY_A_STIA3_2
(V-ABL ABELSON MURINE
LEUKEMIA VIRAL
ONCOGENE HOMOLOG 1
ISOFORM B VARIANT)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 6 LYS A 273
VAL A 291
VAL A 301
ILE A 314
ARG A 363
 1BM  A 499 (-3.8A)
None
None
1BM  A 499 (-3.9A)
None
 1.13A 3pyyA-2hk5A:
27.6		 3pyyA-2hk5A:
45.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PYY_B_STIB4_1
(V-ABL ABELSON MURINE
LEUKEMIA VIRAL
ONCOGENE HOMOLOG 1
ISOFORM B VARIANT)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		10 / 12 LEU A 251
VAL A 259
ALA A 271
GLU A 288
MET A 292
VAL A 301
THR A 316
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 1.02A 3pyyB-2hk5A:
27.3		 3pyyB-2hk5A:
45.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PYY_B_STIB4_2
(V-ABL ABELSON MURINE
LEUKEMIA VIRAL
ONCOGENE HOMOLOG 1
ISOFORM B VARIANT)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 5 LYS A 273
VAL A 291
ILE A 314
MET A 319
 1BM  A 499 (-3.8A)
None
1BM  A 499 (-3.9A)
None
 0.72A 3pyyB-2hk5A:
27.3		 3pyyB-2hk5A:
45.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QLG_A_1N1A601_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		11 / 12 LEU A 251
VAL A 259
ALA A 271
LYS A 273
GLU A 288
MET A 292
VAL A 301
THR A 316
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.53A 3qlgA-2hk5A:
28.0		 3qlgA-2hk5A:
66.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QLG_B_1N1B601_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		10 / 12 LEU A 251
VAL A 259
ALA A 271
GLU A 288
MET A 292
VAL A 301
THR A 316
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.48A 3qlgB-2hk5A:
28.9		 3qlgB-2hk5A:
66.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QLG_B_1N1B601_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 4 LYS A 273
ILE A 314
MET A 319
LYS A 321
 1BM  A 499 (-3.8A)
1BM  A 499 (-3.9A)
None
None
 0.38A 3qlgB-2hk5A:
28.9		 3qlgB-2hk5A:
66.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_A_CUA601_0
(LACCASE-1)		 2qt6 LACCASE
(Lentinus
tigrinus) 		4 / 5 HIS A 394
CYH A 452
ILE A 454
HIS A 457
 CU  A 499 (-3.1A)
CU  A 499 (-2.2A)
CU  A 499 (-3.7A)
CU  A 499 (-3.1A)
 0.32A 3qpkA-2qt6A:
42.8		 3qpkA-2qt6A:
31.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_B_CUB601_0
(LACCASE-1)		 2qt6 LACCASE
(Lentinus
tigrinus) 		4 / 4 HIS A 394
CYH A 452
ILE A 454
HIS A 457
 CU  A 499 (-3.1A)
CU  A 499 (-2.2A)
CU  A 499 (-3.7A)
CU  A 499 (-3.1A)
 0.31A 3qpkB-2qt6A:
42.8		 3qpkB-2qt6A:
31.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RGF_A_BAXA465_2
(CYCLIN-DEPENDENT
KINASE 8)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 7 LEU A 371
VAL A 301
LEU A 295
ASP A 382
 1BM  A 499 (-4.4A)
None
None
1BM  A 499 (-4.4A)
 0.86A 3rgfA-2hk5A:
15.9		 3rgfA-2hk5A:
24.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SAN_A_ZMRA901_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		5 / 12 ARG A  37
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.51A 3sanA-3silA:
20.7		 3sanA-3silA:
21.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SAN_B_ZMRB901_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		5 / 12 ARG A  37
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.51A 3sanB-3silA:
20.8		 3sanB-3silA:
21.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SG9_B_KANB305_1
(APH(2'')-ID)		 1jct GLUCARATE
DEHYDRATASE
(Escherichia
coli) 		4 / 8 ASN A 289
HIS A 368
ASP A 366
GLU A 216
 GKR  A 499 ( 2.9A)
GKR  A 499 (-4.1A)
None
None
 1.03A 3sg9B-1jctA:
0.0		 3sg9B-1jctA:
20.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SUE_D_SUED1201_1
(NS3 PROTEASE, NS4A
PROTEIN)		 1cc1 HYDROGENASE (LARGE
SUBUNIT)
(Desulfomicrobium
baculatum) 		5 / 12 PHE L 420
GLY L 419
ARG L 425
GLY L 252
ALA L 423
 None
None
FCO  L 499 (-4.1A)
None
FCO  L 499 (-3.1A)
 1.14A 3sueD-1cc1L:
undetectable		 3sueD-1cc1L:
18.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SXR_A_1N1A1_1
(CYTOPLASMIC
TYROSINE-PROTEIN
KINASE BMX)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 LEU A 251
VAL A 259
ALA A 271
MET A 292
VAL A 301
ILE A 314
THR A 316
GLY A 322
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.47A 3sxrA-2hk5A:
34.7		 3sxrA-2hk5A:
41.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SXR_B_1N1B2_1
(CYTOPLASMIC
TYROSINE-PROTEIN
KINASE BMX)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 LEU A 251
VAL A 259
ALA A 271
MET A 292
VAL A 301
THR A 316
GLY A 322
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.49A 3sxrB-2hk5A:
22.0		 3sxrB-2hk5A:
41.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TAJ_A_NBOA700_1
(LACTOTRANSFERRIN)		 1k4q GLUTATHIONE
REDUCTASE
(Homo
sapiens) 		4 / 7 THR A 156
GLY A 158
PRO A 293
ASN A 294
 FAD  A 499 (-3.9A)
None
None
FAD  A 499 ( 4.5A)
 0.86A 3tajA-1k4qA:
undetectable		 3tajA-1k4qA:
21.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TI5_A_ZMRA1002_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.78A 3ti5A-3silA:
20.1		 3ti5A-3silA:
22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TI5_B_ZMRB1002_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.80A 3ti5B-3silA:
11.4		 3ti5B-3silA:
22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TIC_A_ZMRA1002_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.76A 3ticA-3silA:
12.8		 3ticA-3silA:
22.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TIC_B_ZMRB1002_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.79A 3ticB-3silA:
20.4		 3ticB-3silA:
22.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TIC_C_ZMRC1002_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.76A 3ticC-3silA:
12.9		 3ticC-3silA:
22.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TIC_D_ZMRD1002_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.77A 3ticD-3silA:
20.3		 3ticD-3silA:
22.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U8Q_A_NPUA7231_1
(LACTOTRANSFERRIN)		 1k4q GLUTATHIONE
REDUCTASE
(Homo
sapiens) 		4 / 5 THR A 156
GLY A 158
PRO A 293
ASN A 294
 FAD  A 499 (-3.9A)
None
None
FAD  A 499 ( 4.5A)
 0.87A 3u8qA-1k4qA:
undetectable		 3u8qA-1k4qA:
22.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U9F_E_CLME221_1
(CHLORAMPHENICOL
ACETYLTRANSFERASE)		 2qt6 LACCASE
(Lentinus
tigrinus) 		3 / 3 PHE A 336
CYH A 452
HIS A 457
 None
CU  A 499 (-2.2A)
CU  A 499 (-3.1A)
 0.95A 3u9fF-2qt6A:
undetectable		 3u9fF-2qt6A:
17.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U9F_I_CLMI221_0
(CHLORAMPHENICOL
ACETYLTRANSFERASE)		 2qt6 LACCASE
(Lentinus
tigrinus) 		3 / 3 PHE A 336
CYH A 452
HIS A 457
 None
CU  A 499 (-2.2A)
CU  A 499 (-3.1A)
 0.90A 3u9fG-2qt6A:
undetectable		 3u9fG-2qt6A:
17.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U9F_K_CLMK221_1
(CHLORAMPHENICOL
ACETYLTRANSFERASE)		 2qt6 LACCASE
(Lentinus
tigrinus) 		3 / 3 PHE A 462
CYH A 452
HIS A 394
 CU  A 499 (-4.9A)
CU  A 499 (-2.2A)
CU  A 499 (-3.1A)
 1.29A 3u9fL-2qt6A:
undetectable		 3u9fL-2qt6A:
17.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U9F_R_CLMR221_1
(CHLORAMPHENICOL
ACETYLTRANSFERASE)		 2qt6 LACCASE
(Lentinus
tigrinus) 		3 / 3 PHE A 336
CYH A 452
HIS A 457
 None
CU  A 499 (-2.2A)
CU  A 499 (-3.1A)
 0.83A 3u9fS-2qt6A:
undetectable		 3u9fS-2qt6A:
17.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UE4_A_DB8A601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 LEU A 251
ALA A 271
LYS A 273
GLU A 288
ILE A 314
THR A 316
PHE A 318
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
 0.81A 3ue4A-2hk5A:
29.8		 3ue4A-2hk5A:
46.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UE4_A_DB8A601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		10 / 12 LEU A 251
ALA A 271
LYS A 273
VAL A 301
ILE A 314
THR A 316
PHE A 318
MET A 319
GLY A 322
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.51A 3ue4A-2hk5A:
29.8		 3ue4A-2hk5A:
46.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UE4_B_DB8B601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 LEU A 251
VAL A 259
ALA A 271
GLU A 288
MET A 292
ILE A 314
THR A 316
PHE A 318
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
 0.73A 3ue4B-2hk5A:
30.6		 3ue4B-2hk5A:
46.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UE4_B_DB8B601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		10 / 12 LEU A 251
VAL A 259
ALA A 271
MET A 292
VAL A 301
ILE A 314
THR A 316
PHE A 318
GLY A 322
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.55A 3ue4B-2hk5A:
30.6		 3ue4B-2hk5A:
46.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UG2_A_IREA1_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 LEU A 251
VAL A 259
ALA A 271
LYS A 273
MET A 319
GLY A 322
ASP A 326
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
None
1BM  A 499 (-3.5A)
None
1BM  A 499 (-4.4A)
 0.76A 3ug2A-2hk5A:
27.5		 3ug2A-2hk5A:
33.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VNS_A_DVAA602_0
(NRPS ADENYLATION
PROTEIN CYTC1)		 3pop GILR OXIDASE
(Streptomyces
griseoflavus) 		4 / 7 ASP A 485
PHE A 195
GLY A 193
THR A 489
 None
None
FAD  A 499 (-3.7A)
None
 0.98A 3vnsA-3popA:
undetectable		 3vnsA-3popA:
24.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WXO_A_NIZA802_1
(CATALASE-PEROXIDASE)		 1k4q GLUTATHIONE
REDUCTASE
(Homo
sapiens) 		4 / 8 LEU A 338
ILE A 367
ASN A 366
GLY A 381
 FAD  A 499 (-3.9A)
None
None
None
 0.87A 3wxoA-1k4qA:
0.0		 3wxoA-1k4qA:
21.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ZBF_A_VGHA3000_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ROS)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 LEU A 251
ALA A 271
MET A 319
GLY A 322
LEU A 371
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 (-4.4A)
 0.54A 3zbfA-2hk5A:
26.1		 3zbfA-2hk5A:
38.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ZOS_A_0LIA1000_1
(EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 ALA A 271
LYS A 273
GLU A 288
THR A 316
HIS A 362
ARG A 363
LEU A 371
ALA A 381
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.2A)
None
None
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 1.01A 3zosA-2hk5A:
29.6		 3zosA-2hk5A:
35.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ZOS_A_0LIA1000_1
(EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 LEU A 251
ALA A 271
LYS A 273
GLU A 288
THR A 316
HIS A 362
LEU A 371
ALA A 381
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.2A)
None
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.96A 3zosA-2hk5A:
29.6		 3zosA-2hk5A:
35.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ZOS_A_0LIA1000_1
(EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 LEU A 251
ALA A 271
LYS A 273
GLU A 288
THR A 316
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 1.01A 3zosA-2hk5A:
29.6		 3zosA-2hk5A:
35.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ZOS_B_0LIB1000_1
(EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 ALA A 271
LYS A 273
GLU A 288
THR A 316
HIS A 362
ARG A 363
LEU A 371
ALA A 381
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.2A)
None
None
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 1.04A 3zosB-2hk5A:
23.5		 3zosB-2hk5A:
35.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4AG8_A_AXIA2000_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 LEU A 251
VAL A 259
ALA A 271
LYS A 273
GLU A 288
VAL A 301
PHE A 318
GLY A 322
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
None
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.94A 4ag8A-2hk5A:
30.6		 4ag8A-2hk5A:
39.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4AGD_A_B49A2000_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 11 LEU A 251
ALA A 271
VAL A 301
PHE A 318
GLY A 322
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
None
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.63A 4agdA-2hk5A:
29.9		 4agdA-2hk5A:
35.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ANQ_A_VGHA9000_1
(ALK TYROSINE KINASE
RECEPTOR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 9 LEU A 251
VAL A 259
ALA A 271
MET A 319
GLY A 322
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.55A 4anqA-2hk5A:
24.9		 4anqA-2hk5A:
37.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ANS_A_VGHA9000_1
(ALK TYROSINE KINASE
RECEPTOR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 9 LEU A 251
VAL A 259
ALA A 271
MET A 319
GLY A 322
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.56A 4ansA-2hk5A:
24.9		 4ansA-2hk5A:
37.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ASD_A_BAXA1500_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 LEU A 251
VAL A 259
ALA A 271
LYS A 273
GLU A 288
PHE A 318
GLY A 322
HIS A 362
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
None
 0.98A 4asdA-2hk5A:
30.3		 4asdA-2hk5A:
35.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4B7N_A_ZMRA601_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.81A 4b7nA-3silA:
11.3		 4b7nA-3silA:
22.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4B7Q_A_ZMRA601_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.88A 4b7qA-3silA:
12.1		 4b7qA-3silA:
22.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4B7Q_B_ZMRB601_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.83A 4b7qB-3silA:
20.1		 4b7qB-3silA:
22.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4B7Q_C_ZMRC601_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.83A 4b7qC-3silA:
11.6		 4b7qC-3silA:
22.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4B7Q_D_ZMRD601_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.84A 4b7qD-3silA:
11.6		 4b7qD-3silA:
22.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4BKJ_A_STIA1000_1
(EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 ALA A 271
MET A 292
THR A 316
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.85A 4bkjA-2hk5A:
29.3		 4bkjA-2hk5A:
35.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4BKJ_B_STIB1000_1
(EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 ALA A 271
MET A 292
THR A 316
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.83A 4bkjB-2hk5A:
29.3		 4bkjB-2hk5A:
35.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4BKJ_B_STIB1000_1
(EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 VAL A 259
ALA A 271
GLU A 288
MET A 292
THR A 316
ASP A 382
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.4A)
 1.06A 4bkjB-2hk5A:
29.3		 4bkjB-2hk5A:
35.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4BKJ_B_STIB1000_1
(EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 VAL A 259
ALA A 271
MET A 292
THR A 316
ALA A 381
ASP A 382
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 1.00A 4bkjB-2hk5A:
29.3		 4bkjB-2hk5A:
35.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C8B_A_0LIA1000_1
(RECEPTOR-INTERACTING
SERINE/THREONINE-PRO
TEIN KINASE 2)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 ALA A 271
LYS A 273
GLU A 288
ILE A 314
THR A 316
HIS A 362
LEU A 371
ALA A 381
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
None
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.78A 4c8bA-2hk5A:
26.4		 4c8bA-2hk5A:
25.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C8B_A_0LIA1000_1
(RECEPTOR-INTERACTING
SERINE/THREONINE-PRO
TEIN KINASE 2)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 ALA A 271
LYS A 273
ILE A 314
THR A 316
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.66A 4c8bA-2hk5A:
26.4		 4c8bA-2hk5A:
25.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4CKI_A_ADNA2022_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE RECEPTOR RET)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 11 LEU A 251
GLY A 252
VAL A 259
ALA A 271
GLY A 322
SER A 323
LEU A 371
 1BM  A 499 ( 3.7A)
None
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.5A)
None
1BM  A 499 (-4.4A)
 0.49A 4ckiA-2hk5A:
30.3		 4ckiA-2hk5A:
40.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4CKJ_A_ADNA2014_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE RECEPTOR RET)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 10 LEU A 251
GLY A 252
GLY A 254
VAL A 259
ALA A 271
SER A 323
LEU A 371
 1BM  A 499 ( 3.7A)
None
None
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
None
1BM  A 499 (-4.4A)
 0.55A 4ckjA-2hk5A:
29.0		 4ckjA-2hk5A:
39.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CPN_A_ZMRA700_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.81A 4cpnA-3silA:
23.5		 4cpnA-3silA:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CPN_B_ZMRB700_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.81A 4cpnB-3silA:
23.5		 4cpnB-3silA:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CPZ_A_ZMRA1471_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		5 / 12 ARG A  37
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.53A 4cpzA-3silA:
23.4		 4cpzA-3silA:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CPZ_B_ZMRB1471_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		5 / 12 ARG A  37
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.49A 4cpzB-3silA:
23.5		 4cpzB-3silA:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CPZ_C_ZMRC1470_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.80A 4cpzC-3silA:
23.3		 4cpzC-3silA:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CPZ_D_ZMRD1471_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		5 / 12 ARG A  37
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.46A 4cpzD-3silA:
23.5		 4cpzD-3silA:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CPZ_E_ZMRE1471_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.89A 4cpzE-3silA:
23.5		 4cpzE-3silA:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CPZ_F_ZMRF1470_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.86A 4cpzF-3silA:
23.6		 4cpzF-3silA:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CPZ_G_ZMRG1471_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.77A 4cpzG-3silA:
23.6		 4cpzG-3silA:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CPZ_H_ZMRH1470_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.86A 4cpzH-3silA:
23.5		 4cpzH-3silA:
22.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4CSV_A_STIA1265_1
(SRC-ABL TYROSINE
KINASE ANCESTOR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 VAL A 259
ALA A 271
GLU A 288
MET A 292
VAL A 301
THR A 316
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 1.02A 4csvA-2hk5A:
28.0		 4csvA-2hk5A:
58.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTJ_C_SAMC1263_0
(NON-STRUCTURAL
PROTEIN 5)		 3pop GILR OXIDASE
(Streptomyces
griseoflavus) 		5 / 12 GLY A 129
GLY A 137
GLY A 131
HIS A 152
VAL A 392
 FAD  A 499 (-3.6A)
None
FAD  A 499 (-3.5A)
None
None
 0.93A 4ctjC-3popA:
undetectable		 4ctjC-3popA:
20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D7H_A_H4BA902_1
(NITRIC OXIDE
SYNTHASE OXYGENASE)		 3g25 GLYCEROL KINASE
(Staphylococcus
aureus) 		3 / 3 ARG A 105
THR A  84
TRP A 102
 None
None
GOL  A 499 (-3.4A)
 1.17A 4d7hA-3g25A:
undetectable		 4d7hA-3g25A:
21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_B_2FAB301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)		 3pop GILR OXIDASE
(Streptomyces
griseoflavus) 		5 / 12 ARG A 338
GLY A  72
VAL A  30
GLU A  31
VAL A  71
 None
None
None
None
FAD  A 499 ( 4.5A)
 1.20A 4danA-3popA:
undetectable
4danB-3popA:
undetectable		 4danA-3popA:
19.04
4danB-3popA:
19.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EMA_A_BRLA601_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)		 1cc1 HYDROGENASE (LARGE
SUBUNIT)
(Desulfomicrobium
baculatum) 		5 / 12 CYH L 492
HIS L 498
HIS L  77
LEU L 428
LEU L 449
 NI  L 500 (-2.4A)
FE2  L 501 (-3.5A)
FCO  L 499 (-3.9A)
FCO  L 499 (-3.5A)
None
 1.35A 4emaA-1cc1L:
undetectable		 4emaA-1cc1L:
20.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FJP_A_NPSA711_1
(LACTOTRANSFERRIN)		 1k4q GLUTATHIONE
REDUCTASE
(Homo
sapiens) 		4 / 6 THR A 156
GLY A 158
PRO A 293
ASN A 294
 FAD  A 499 (-3.9A)
None
None
FAD  A 499 ( 4.5A)
 0.91A 4fjpA-1k4qA:
undetectable		 4fjpA-1k4qA:
22.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FOR_A_FLPA711_1
(LACTOTRANSFERRIN)		 1k4q GLUTATHIONE
REDUCTASE
(Homo
sapiens) 		4 / 7 THR A 156
GLY A 158
PRO A 293
ASN A 294
 FAD  A 499 (-3.9A)
None
None
FAD  A 499 ( 4.5A)
 0.82A 4forA-1k4qA:
undetectable		 4forA-1k4qA:
22.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4G0U_F_ASWF101_1
(DNA TOPOISOMERASE
2-BETA)		 1btc BETA-AMYLASE
(Glycine
max) 		4 / 6 GLY A 298
ALA A 184
GLU A 186
GLN A 351
 BME  A 504 ( 4.3A)
BME  A 502 ( 3.9A)
None
GLC  A 499 ( 3.6A)
 1.09A 4g0uA-1btcA:
undetectable		 4g0uA-1btcA:
21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4H2G_A_ADNA603_1
(5'-NUCLEOTIDASE)		 3pop GILR OXIDASE
(Streptomyces
griseoflavus) 		5 / 9 ASN A 194
GLY A 191
GLY A 192
PHE A  70
GLY A 190
 None
None
FAD  A 499 (-3.4A)
None
None
 1.23A 4h2gA-3popA:
undetectable		 4h2gA-3popA:
22.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HJO_A_AQ4A1001_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 LEU A 251
VAL A 259
ALA A 271
THR A 316
MET A 319
GLY A 322
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.35A 4hjoA-2hk5A:
29.9		 4hjoA-2hk5A:
33.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4I00_A_ZMRA509_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.76A 4i00A-3silA:
19.7		 4i00A-3silA:
23.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K37_B_SAMB504_0
(ANAEROBIC
SULFATASE-MATURATING
ENZYME)		 3nv9 MALIC ENZYME
(Entamoeba
histolytica) 		5 / 11 TYR A 271
GLN A 195
ASN A 174
LEU A 179
VAL A 181
 None
None
GOL  A 499 ( 4.9A)
None
None
 1.44A 4k37B-3nv9A:
undetectable		 4k37B-3nv9A:
21.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KS8_A_B49A701_1
(SERINE/THREONINE-PRO
TEIN KINASE PAK 6)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 10 ALA A 271
VAL A 301
PHE A 318
GLY A 322
LEU A 371
 1BM  A 499 (-3.6A)
None
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.35A 4ks8A-2hk5A:
19.4		 4ks8A-2hk5A:
27.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4L9I_A_8PRA601_1
(RHODOPSIN KINASE)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 7 VAL A 259
ALA A 271
MET A 319
LEU A 371
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
None
1BM  A 499 (-4.4A)
 0.82A 4l9iA-2hk5A:
10.2		 4l9iA-2hk5A:
20.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4L9I_B_8PRB601_1
(RHODOPSIN KINASE)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 8 VAL A 259
ALA A 271
LYS A 273
MET A 319
LEU A 371
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
None
1BM  A 499 (-4.4A)
 0.79A 4l9iB-2hk5A:
20.1		 4l9iB-2hk5A:
20.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LAJ_B_ACAB512_1
(HIV-1 YU2 GP120
ENVELOPE
GLYCOPROTEIN)		 1e8c UDP-N-ACETYLMURAMOYL
ALANYL-D-GLUTAMATE--
2,6-DIAMINOPIMELATE
LIGASE
(Escherichia
coli) 		4 / 6 ARG A 443
GLY A 442
ASP A 413
PRO A 415
 None
None
API  A1499 (-3.6A)
None
 1.05A 4lajA-1e8cA:
0.0
4lajB-1e8cA:
0.0		 4lajA-1e8cA:
19.85
4lajB-1e8cA:
19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LTW_A_486A302_1
(ANCESTRAL STEROID
RECEPTOR 2)		 4y85 MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 8
(Homo
sapiens) 		6 / 12 VAL A 249
LEU A 273
ILE A 181
GLN A 182
ILE A 190
ALA A 191
 None
None
None
None
None
499  A 401 ( 4.6A)
 1.35A 4ltwA-4y85A:
undetectable		 4ltwA-4y85A:
21.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4MKC_A_4MKA1503_1
(ALK TYROSINE KINASE
RECEPTOR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 LEU A 251
VAL A 259
ALA A 271
LYS A 273
GLY A 322
LEU A 371
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 (-4.4A)
 0.64A 4mkcA-2hk5A:
24.3		 4mkcA-2hk5A:
33.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MWR_A_ZMRA513_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		5 / 12 ARG A  37
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.53A 4mwrA-3silA:
19.7		 4mwrA-3silA:
22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MWX_A_ZMRA513_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		5 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.77A 4mwxA-3silA:
19.7		 4mwxA-3silA:
22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MX0_A_BCZA513_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		3 / 3 ARG A  37
ASP A  62
ARG A 309
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
PO4  A 499 (-3.0A)
 0.77A 4mx0A-3silA:
6.7		 4mx0A-3silA:
22.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4MXO_A_DB8A601_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		11 / 12 LEU A 251
VAL A 259
ALA A 271
LYS A 273
GLU A 288
MET A 292
VAL A 301
ILE A 314
THR A 316
GLY A 322
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.69A 4mxoA-2hk5A:
29.9		 4mxoA-2hk5A:
67.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4MXO_B_DB8B601_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		11 / 12 LEU A 251
VAL A 259
ALA A 271
LYS A 273
GLU A 288
VAL A 301
ILE A 314
THR A 316
GLY A 322
LEU A 371
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 (-4.4A)
 0.74A 4mxoB-2hk5A:
29.8		 4mxoB-2hk5A:
67.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4MXX_A_DB8A601_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		10 / 12 LEU A 251
ALA A 271
LYS A 273
GLU A 288
MET A 292
VAL A 301
ILE A 314
THR A 316
GLY A 322
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.66A 4mxxA-2hk5A:
29.5		 4mxxA-2hk5A:
66.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4MXX_B_DB8B601_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 LEU A 251
VAL A 259
ALA A 271
LYS A 273
VAL A 301
THR A 316
MET A 319
GLY A 322
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
None
1BM  A 499 (-3.2A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.61A 4mxxB-2hk5A:
27.1		 4mxxB-2hk5A:
66.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4MXY_A_DB8A601_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		10 / 12 LEU A 251
VAL A 259
ALA A 271
LYS A 273
GLU A 288
VAL A 301
ILE A 314
GLY A 322
LEU A 371
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 (-4.4A)
 0.64A 4mxyA-2hk5A:
28.4		 4mxyA-2hk5A:
66.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4MXY_B_DB8B601_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 LEU A 251
VAL A 259
ALA A 271
GLU A 288
VAL A 301
GLY A 322
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.62A 4mxyB-2hk5A:
28.6		 4mxyB-2hk5A:
66.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4MXZ_A_DB8A601_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		10 / 12 LEU A 251
VAL A 259
ALA A 271
LYS A 273
GLU A 288
VAL A 301
ILE A 314
GLY A 322
LEU A 371
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 (-4.4A)
 0.64A 4mxzA-2hk5A:
28.4		 4mxzA-2hk5A:
66.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4MXZ_B_DB8B601_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 LEU A 251
VAL A 259
ALA A 271
GLU A 288
VAL A 301
GLY A 322
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.62A 4mxzB-2hk5A:
28.6		 4mxzB-2hk5A:
66.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NKV_C_AERC601_2
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)		 3g25 GLYCEROL KINASE
(Staphylococcus
aureus) 		4 / 6 ASP A 244
GLU A 436
VAL A 412
ALA A 411
 GOL  A 499 ( 2.8A)
None
None
None
 0.95A 4nkvC-3g25A:
undetectable		 4nkvC-3g25A:
22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OGR_A_ADNA401_1
(CYCLIN-DEPENDENT
KINASE 9)		 4y85 MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 8
(Homo
sapiens) 		5 / 8 GLY A 147
VAL A 152
ALA A 165
ASN A 258
ASP A 270
 499  A 401 (-3.3A)
499  A 401 (-4.6A)
499  A 401 (-3.2A)
499  A 401 ( 4.8A)
499  A 401 (-3.7A)
 0.60A 4ogrA-4y85A:
26.9		 4ogrA-4y85A:
23.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OTW_A_DB8A1101_1
(RECEPTOR
TYROSINE-PROTEIN
KINASE ERBB-3)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 LEU A 251
VAL A 259
LYS A 273
VAL A 301
THR A 316
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.75A 4otwA-2hk5A:
24.7		 4otwA-2hk5A:
31.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OTW_A_DB8A1101_1
(RECEPTOR
TYROSINE-PROTEIN
KINASE ERBB-3)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 LYS A 273
VAL A 301
THR A 316
GLY A 322
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 (-3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.90A 4otwA-2hk5A:
24.7		 4otwA-2hk5A:
31.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PGF_B_ADNB502_2
(ADENOSYLHOMOCYSTEINA
SE)		 1e8c UDP-N-ACETYLMURAMOYL
ALANYL-D-GLUTAMATE--
2,6-DIAMINOPIMELATE
LIGASE
(Escherichia
coli) 		4 / 5 THR A 122
THR A 123
HIS A 359
ASN A 205
 None
None
API  A1499 (-3.7A)
None
 1.28A 4pgfB-1e8cA:
2.6		 4pgfB-1e8cA:
23.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QB9_D_PARD500_1
(ENHANCED
INTRACELLULAR
SURVIVAL PROTEIN)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 8 PHE A 487
SER A 425
GLU A 288
ASP A 382
 None
None
1BM  A 499 (-3.2A)
1BM  A 499 (-4.4A)
 1.40A 4qb9D-2hk5A:
undetectable		 4qb9D-2hk5A:
19.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QRC_A_0LIA802_1
(FIBROBLAST GROWTH
FACTOR RECEPTOR 4)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 ALA A 271
GLU A 288
MET A 292
ARG A 363
ALA A 381
ASP A 382
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 1.37A 4qrcA-2hk5A:
31.2		 4qrcA-2hk5A:
39.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QWP_B_GCSB307_1
(CHITOSANASE)		 1e8c UDP-N-ACETYLMURAMOYL
ALANYL-D-GLUTAMATE--
2,6-DIAMINOPIMELATE
LIGASE
(Escherichia
coli) 		4 / 7 GLU A 468
THR A 142
THR A 157
HIS A 359
 API  A1499 (-3.1A)
None
UAG  A1498 (-3.9A)
API  A1499 (-3.7A)
 0.91A 4qwpB-1e8cA:
undetectable		 4qwpB-1e8cA:
21.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4R7I_A_STIA1001_1
(MACROPHAGE
COLONY-STIMULATING
FACTOR 1 RECEPTOR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 VAL A 259
ALA A 271
LYS A 273
GLU A 288
MET A 292
THR A 316
LEU A 371
ASP A 382
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.4A)
1BM  A 499 (-4.4A)
 0.89A 4r7iA-2hk5A:
24.9		 4r7iA-2hk5A:
36.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RZV_A_032A801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 12 ALA A 271
LYS A 273
ILE A 314
THR A 316
SER A 323
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
None
 0.57A 4rzvA-2hk5A:
26.3		 4rzvA-2hk5A:
32.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RZV_A_032A801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 12 ALA A 271
LYS A 273
THR A 316
SER A 323
PHE A 383
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
None
None
 0.93A 4rzvA-2hk5A:
26.3		 4rzvA-2hk5A:
32.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RZV_B_032B801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 12 VAL A 259
ALA A 271
LYS A 273
THR A 316
PHE A 383
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
None
 0.77A 4rzvB-2hk5A:
25.9		 4rzvB-2hk5A:
32.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RZV_B_032B801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 12 VAL A 259
ALA A 271
LYS A 273
THR A 316
SER A 323
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
None
 0.63A 4rzvB-2hk5A:
25.9		 4rzvB-2hk5A:
32.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4TWP_A_AXIA601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		10 / 12 LEU A 251
VAL A 259
ALA A 271
LYS A 273
PHE A 318
MET A 319
GLY A 322
ASN A 369
LEU A 371
ALA A 381
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-4.1A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.80A 4twpA-2hk5A:
31.7		 4twpA-2hk5A:
48.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4TWP_A_AXIA601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		10 / 12 VAL A 259
ALA A 271
LYS A 273
PHE A 318
MET A 319
GLY A 322
ASN A 369
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-4.1A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.77A 4twpA-2hk5A:
31.7		 4twpA-2hk5A:
48.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4TWP_B_AXIB601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		11 / 12 LEU A 251
VAL A 259
ALA A 271
LYS A 273
PHE A 318
MET A 319
GLY A 322
ASN A 369
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-4.1A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.81A 4twpB-2hk5A:
31.6		 4twpB-2hk5A:
48.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4TYJ_A_0LIA801_1
(FIBROBLAST GROWTH
FACTOR RECEPTOR 4)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 ALA A 271
GLU A 288
MET A 292
HIS A 362
LEU A 371
ALA A 381
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.75A 4tyjA-2hk5A:
26.1		 4tyjA-2hk5A:
41.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4U0I_A_0LIA1001_2
(MAST/STEM CELL
GROWTH FACTOR
RECEPTOR
KIT,MAST/STEM CELL
GROWTH FACTOR
RECEPTOR KIT)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 ALA A 271
LYS A 273
THR A 316
GLY A 322
HIS A 362
LEU A 371
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
None
1BM  A 499 (-4.4A)
 0.60A 4u0iA-2hk5A:
31.3		 4u0iA-2hk5A:
38.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4U0I_A_0LIA1001_2
(MAST/STEM CELL
GROWTH FACTOR
RECEPTOR
KIT,MAST/STEM CELL
GROWTH FACTOR
RECEPTOR KIT)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 ALA A 271
LYS A 273
THR A 316
GLY A 322
LEU A 371
ASP A 382
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 (-4.4A)
 0.66A 4u0iA-2hk5A:
31.3		 4u0iA-2hk5A:
38.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4U5J_A_RXTA601_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 11 LEU A 251
VAL A 259
ALA A 271
MET A 319
GLY A 322
ASN A 369
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.50A 4u5jA-2hk5A:
30.2		 4u5jA-2hk5A:
67.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4U5J_B_RXTB601_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 9 LEU A 251
VAL A 259
ALA A 271
MET A 319
GLY A 322
LEU A 371
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 (-4.4A)
 0.49A 4u5jB-2hk5A:
29.7		 4u5jB-2hk5A:
67.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UG5_A_H4BA902_1
(NITRIC OXIDE
SYNTHASE OXYGENASE)		 3g25 GLYCEROL KINASE
(Staphylococcus
aureus) 		3 / 3 ARG A 105
THR A  84
TRP A 102
 None
None
GOL  A 499 (-3.4A)
 1.13A 4ug5A-3g25A:
undetectable		 4ug5A-3g25A:
21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UGL_A_H4BA902_1
(NITRIC OXIDE
SYNTHASE)		 3g25 GLYCEROL KINASE
(Staphylococcus
aureus) 		3 / 3 ARG A 105
THR A  84
TRP A 102
 None
None
GOL  A 499 (-3.4A)
 1.17A 4uglA-3g25A:
undetectable		 4uglA-3g25A:
21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4USW_A_ACTA1470_0
(ADENYLATE CYCLASE
TYPE 10)		 1jct GLUCARATE
DEHYDRATASE
(Escherichia
coli) 		4 / 6 LEU A 206
LEU A 191
VAL A 188
PHE A 152
 None
None
None
GKR  A 499 (-4.7A)
 1.03A 4uswA-1jctA:
0.0		 4uswA-1jctA:
22.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4V04_A_0LIA1772_1
(FIBROBLAST GROWTH
FACTOR RECEPTOR 1
(FMS-RELATED
TYROSINE KINASE 2,
PFEIFFER SYNDROME),
ISOFORM CRA_B)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 VAL A 259
ALA A 271
GLU A 288
HIS A 362
ALA A 381
GLY A 384
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
None
1BM  A 499 ( 3.7A)
None
 1.33A 4v04A-2hk5A:
24.4		 4v04A-2hk5A:
38.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4V04_A_0LIA1772_2
(FIBROBLAST GROWTH
FACTOR RECEPTOR 1
(FMS-RELATED
TYROSINE KINASE 2,
PFEIFFER SYNDROME),
ISOFORM CRA_B)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 8 LYS A 273
MET A 292
ARG A 363
LEU A 371
ILE A 380
 1BM  A 499 (-3.8A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-4.4A)
None
 1.34A 4v04A-2hk5A:
24.4		 4v04A-2hk5A:
38.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4V04_B_0LIB1771_1
(FIBROBLAST GROWTH
FACTOR RECEPTOR 1
(FMS-RELATED
TYROSINE KINASE 2,
PFEIFFER SYNDROME),
ISOFORM CRA_B)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 10 LEU A 251
VAL A 259
LYS A 273
MET A 292
LEU A 371
ILE A 380
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.8A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-4.4A)
None
 0.94A 4v04B-2hk5A:
24.7		 4v04B-2hk5A:
38.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WA5_A_ZMRA501_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.87A 4wa5A-3silA:
12.6		 4wa5A-3silA:
23.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4WA9_A_AXIA9000_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 11 ALA A 271
LYS A 273
THR A 316
MET A 319
GLY A 322
ASN A 369
LEU A 371
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
 1.10A 4wa9A-2hk5A:
31.9		 4wa9A-2hk5A:
46.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4WA9_A_AXIA9000_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 11 LEU A 251
ALA A 271
THR A 316
MET A 319
GLY A 322
ASN A 369
LEU A 371
ALA A 381
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.45A 4wa9A-2hk5A:
31.9		 4wa9A-2hk5A:
46.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4WA9_B_AXIB9000_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 VAL A 259
ALA A 271
LYS A 273
THR A 316
PHE A 318
MET A 319
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.79A 4wa9B-2hk5A:
35.2		 4wa9B-2hk5A:
46.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4WA9_B_AXIB9000_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 VAL A 259
ALA A 271
THR A 316
PHE A 318
MET A 319
GLY A 322
ASN A 369
LEU A 371
ALA A 381
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.69A 4wa9B-2hk5A:
35.2		 4wa9B-2hk5A:
46.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WBO_C_ANWC601_0
(RHODOPSIN KINASE)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 6 LEU A 251
ALA A 271
MET A 319
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
None
1BM  A 499 (-4.4A)
 0.59A 4wboC-2hk5A:
24.1		 4wboC-2hk5A:
19.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4WKQ_A_IREA1101_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 LEU A 251
ALA A 271
LYS A 273
GLU A 288
MET A 292
THR A 316
GLY A 322
ASP A 326
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
None
1BM  A 499 (-4.4A)
 0.63A 4wkqA-2hk5A:
33.3		 4wkqA-2hk5A:
34.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4XEY_A_1N1A601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		11 / 12 LEU A 251
VAL A 259
ALA A 271
LYS A 273
MET A 292
VAL A 301
ILE A 314
THR A 316
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.63A 4xeyA-2hk5A:
29.4		 4xeyA-2hk5A:
36.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4XEY_A_1N1A601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		11 / 12 LEU A 251
VAL A 259
ALA A 271
MET A 292
VAL A 301
ILE A 314
THR A 316
PHE A 318
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.57A 4xeyA-2hk5A:
29.4		 4xeyA-2hk5A:
36.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4XEY_B_1N1B601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 ALA A 271
LYS A 273
MET A 292
VAL A 301
ILE A 314
THR A 316
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.63A 4xeyB-2hk5A:
29.9		 4xeyB-2hk5A:
36.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4XEY_B_1N1B601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		11 / 12 LEU A 251
VAL A 259
ALA A 271
MET A 292
VAL A 301
ILE A 314
THR A 316
PHE A 318
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.56A 4xeyB-2hk5A:
29.9		 4xeyB-2hk5A:
36.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4XLI_A_1N1A601_1
(NON-SPECIFIC
PROTEIN-TYROSINE
KINASE)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		10 / 12 LEU A 251
ALA A 271
GLU A 288
MET A 292
VAL A 301
THR A 316
MET A 319
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.49A 4xliA-2hk5A:
31.5		 4xliA-2hk5A:
48.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4XLI_A_1N1A601_1
(NON-SPECIFIC
PROTEIN-TYROSINE
KINASE)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		10 / 12 LEU A 251
ALA A 271
LYS A 273
GLU A 288
MET A 292
VAL A 301
THR A 316
MET A 319
GLY A 322
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.67A 4xliA-2hk5A:
31.5		 4xliA-2hk5A:
48.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4XLI_B_1N1B600_1
(NON-SPECIFIC
PROTEIN-TYROSINE
KINASE)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		11 / 12 LEU A 251
ALA A 271
LYS A 273
GLU A 288
MET A 292
VAL A 301
ILE A 314
THR A 316
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.49A 4xliB-2hk5A:
30.4		 4xliB-2hk5A:
48.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ZAU_A_YY3A1101_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 8 LEU A 251
GLY A 252
VAL A 259
ALA A 271
MET A 319
GLY A 322
 1BM  A 499 ( 3.7A)
None
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
None
1BM  A 499 (-3.5A)
 0.43A 4zauA-2hk5A:
33.7		 4zauA-2hk5A:
34.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZJZ_B_BEZB601_0
(BENZOATE-COENZYME A
LIGASE)		 1k4q GLUTATHIONE
REDUCTASE
(Homo
sapiens) 		5 / 8 ALA A 155
VAL A  25
GLY A  31
ALA A 342
GLY A 346
 FAD  A 499 (-4.5A)
None
FAD  A 499 (-3.7A)
FAD  A 499 ( 3.7A)
None
 1.26A 4zjzB-1k4qA:
undetectable		 4zjzB-1k4qA:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZZB_C_ACTC401_0
(PROTON-GATED ION
CHANNEL)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		4 / 7 ILE A 506
ARG A 499
VAL A 497
GLU A 478
 ILE  A 506 ( 0.7A)
ARG  A 499 ( 0.6A)
VAL  A 497 ( 0.6A)
GLU  A 478 ( 0.6A)
 0.93A 4zzbC-5gprA:
undetectable
4zzbD-5gprA:
undetectable		 4zzbC-5gprA:
20.43
4zzbD-5gprA:
20.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5AAA_A_VGHA9000_1
(ALK TYROSINE KINASE
RECEPTOR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 9 LEU A 251
VAL A 259
ALA A 271
MET A 319
GLY A 322
LEU A 371
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 (-4.4A)
 0.52A 5aaaA-2hk5A:
24.1		 5aaaA-2hk5A:
37.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5AAB_A_VGHA9000_1
(ALK TYROSINE KINASE
RECEPTOR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 10 LEU A 251
VAL A 259
ALA A 271
LYS A 273
MET A 319
GLY A 322
LEU A 371
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 (-4.4A)
 0.71A 5aabA-2hk5A:
31.9		 5aabA-2hk5A:
37.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5AAC_A_VGHA9000_1
(ALK TYROSINE KINASE
RECEPTOR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 10 LEU A 251
VAL A 259
ALA A 271
LYS A 273
MET A 319
GLY A 322
LEU A 371
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 (-4.4A)
 0.77A 5aacA-2hk5A:
31.7		 5aacA-2hk5A:
36.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AJQ_A_DB8A800_1
(SERINE/THREONINE-PRO
TEIN KINASE 10)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 LEU A 251
GLY A 252
ALA A 271
PHE A 318
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 ( 3.7A)
None
1BM  A 499 (-3.6A)
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.83A 5ajqA-2hk5A:
23.3		 5ajqA-2hk5A:
26.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AJQ_A_DB8A800_1
(SERINE/THREONINE-PRO
TEIN KINASE 10)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 LEU A 251
GLY A 252
PHE A 318
GLY A 322
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 3.7A)
None
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.99A 5ajqA-2hk5A:
23.3		 5ajqA-2hk5A:
26.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AJQ_B_DB8B800_1
(SERINE/THREONINE-PRO
TEIN KINASE 10)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 10 ALA A 271
PHE A 318
GLY A 322
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 (-3.6A)
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.73A 5ajqB-2hk5A:
24.0		 5ajqB-2hk5A:
26.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5BVW_A_1N1A1009_1
(EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		10 / 12 LEU A 251
VAL A 259
ALA A 271
LYS A 273
GLU A 288
MET A 292
THR A 316
GLY A 322
LEU A 371
ALA A 381
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.86A 5bvwA-2hk5A:
30.2		 5bvwA-2hk5A:
34.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CDP_H_EVPH2101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT B)		 1k4q GLUTATHIONE
REDUCTASE
(Homo
sapiens) 		4 / 6 SER A  51
GLY A 330
ASP A 331
GLY A  31
 FAD  A 499 (-3.1A)
FAD  A 499 (-3.3A)
FAD  A 499 (-2.9A)
FAD  A 499 (-3.7A)
 0.86A 5cdpA-1k4qA:
undetectable
5cdpB-1k4qA:
undetectable		 5cdpA-1k4qA:
22.16
5cdpB-1k4qA:
19.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5CSW_B_P06B801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 12 VAL A 259
ALA A 271
LYS A 273
THR A 316
PHE A 383
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
None
 0.87A 5cswB-2hk5A:
26.5		 5cswB-2hk5A:
32.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CZY_A_SAMA603_0
(LEGIONELLA EFFECTOR
LEGAS4)		 1k4q GLUTATHIONE
REDUCTASE
(Homo
sapiens) 		5 / 12 LEU A  33
GLY A  32
SER A  51
TYR A 114
LEU A 118
 NIY  A 114 ( 4.1A)
None
FAD  A 499 (-3.1A)
NIY  A 114 ( 1.2A)
NIY  A 114 ( 3.9A)
 0.96A 5czyA-1k4qA:
0.0		 5czyA-1k4qA:
20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6C_A_H4BA902_1
(NITRIC OXIDE
SYNTHASE OXYGENASE)		 3g25 GLYCEROL KINASE
(Staphylococcus
aureus) 		3 / 3 ARG A 105
THR A  84
TRP A 102
 None
None
GOL  A 499 (-3.4A)
 1.15A 5g6cA-3g25A:
undetectable		 5g6cA-3g25A:
21.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5GWY_E_010E6_0
(N-[(5-METHYLISOXAZOL
-3-YL)CARBONYL]ALANY
L-L-VALYL-N~1~-((1R,
2Z)-4-(BENZYLOXY)-4-
OXO-1-{[(3R)-2-OXOPY
RROLIDIN-3-YL]METHYL
}BUT-2-ENYL)-L-LEUCI
NAMIDE
MAIN PROTEASE)		 1cc1 HYDROGENASE (LARGE
SUBUNIT)
(Desulfomicrobium
baculatum) 		4 / 4 THR L 421
LEU L 428
HIS L  77
GLY L 426
 None
FCO  L 499 (-3.5A)
FCO  L 499 (-3.9A)
None
 1.24A 5gwyA-1cc1L:
0.0		 5gwyA-1cc1L:
21.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5H2U_A_1N1A501_1
(PROTEIN-TYROSINE
KINASE 6)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 LEU A 251
VAL A 259
ALA A 271
THR A 316
GLY A 322
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.36A 5h2uA-2hk5A:
24.5		 5h2uA-2hk5A:
45.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5H2U_B_1N1B501_1
(PROTEIN-TYROSINE
KINASE 6)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 LEU A 251
VAL A 259
ALA A 271
ILE A 314
THR A 316
GLY A 322
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.44A 5h2uB-2hk5A:
24.5		 5h2uB-2hk5A:
45.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5H2U_C_1N1C501_1
(PROTEIN-TYROSINE
KINASE 6)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 LEU A 251
ALA A 271
ILE A 314
THR A 316
GLY A 322
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.49A 5h2uC-2hk5A:
24.5		 5h2uC-2hk5A:
45.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5H2U_D_1N1D504_1
(PROTEIN-TYROSINE
KINASE 6)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 LEU A 251
VAL A 259
ALA A 271
ILE A 314
THR A 316
GLY A 322
LEU A 371
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.42A 5h2uD-2hk5A:
24.7		 5h2uD-2hk5A:
45.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HES_A_032A401_1
(MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE MLT)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 12 VAL A 259
ALA A 271
ILE A 314
THR A 316
ASP A 326
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
None
 0.59A 5hesA-2hk5A:
25.7		 5hesA-2hk5A:
26.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HES_A_032A401_2
(MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE MLT)		 4y85 MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 8
(Homo
sapiens) 		4 / 6 LYS A 167
SER A 214
VAL A 260
ASP A 270
 499  A 401 (-2.8A)
499  A 401 (-3.7A)
499  A 401 (-4.6A)
499  A 401 (-3.7A)
 0.69A 5hesA-4y85A:
7.7		 5hesA-4y85A:
27.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HES_B_032B401_1
(MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE MLT)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 VAL A 259
ALA A 271
LYS A 273
ILE A 314
THR A 316
ASP A 326
PHE A 383
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
None
None
 0.79A 5hesB-2hk5A:
25.8		 5hesB-2hk5A:
26.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HIE_A_P06A801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 12 VAL A 259
ALA A 271
LYS A 273
ILE A 314
THR A 316
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
 0.58A 5hieA-2hk5A:
25.5		 5hieA-2hk5A:
30.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HIE_B_P06B801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 12 VAL A 259
ALA A 271
LYS A 273
ILE A 314
THR A 316
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
 0.58A 5hieB-2hk5A:
25.5		 5hieB-2hk5A:
30.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HIE_D_P06D801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 12 VAL A 259
ALA A 271
LYS A 273
ILE A 314
THR A 316
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
 0.57A 5hieD-2hk5A:
25.7		 5hieD-2hk5A:
30.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HIE_D_P06D801_2
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 3snx PUTATIVE SUSD-LIKE
CARBOHYDRATE BINDING
PROTEIN
(Bacteroides
thetaiotaomicron) 		4 / 8 GLY A 416
PHE A 471
PHE A 462
ASP A  82
 EDO  A 499 (-4.2A)
None
None
None
 0.93A 5hieD-3snxA:
undetectable		 5hieD-3snxA:
21.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5I9X_A_DB8A1001_1
(EPHRIN TYPE-A
RECEPTOR 2)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 ALA A 271
LYS A 273
GLU A 288
ILE A 314
THR A 316
GLY A 322
LEU A 371
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.72A 5i9xA-2hk5A:
33.3		 5i9xA-2hk5A:
41.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5I9Y_A_1N1A1001_1
(EPHRIN TYPE-A
RECEPTOR 2)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 ALA A 271
LYS A 273
GLU A 288
MET A 292
THR A 316
GLY A 322
LEU A 371
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.49A 5i9yA-2hk5A:
25.2		 5i9yA-2hk5A:
41.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IZJ_F_AZ1F2_1
(CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA
47P-AZ1-DAR-DAR-DAR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 7 GLY A 252
GLY A 254
GLY A 257
VAL A 259
 None
None
None
1BM  A 499 ( 4.8A)
 0.24A 5izjB-2hk5A:
17.5		 5izjB-2hk5A:
23.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IZJ_G_AZ1G2_1
(CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA
47P-AZ1-DAR-DAR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 7 GLY A 252
GLY A 254
VAL A 259
LYS A 273
 None
None
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.8A)
 0.46A 5izjA-2hk5A:
18.9		 5izjA-2hk5A:
23.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5J5X_B_AZ1B2_1
(CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA
47P-AZ1-DAL-DAR-DAR-
DAR-DAR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 7 GLY A 252
GLY A 254
VAL A 259
LYS A 273
 None
None
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.8A)
 0.39A 5j5xA-2hk5A:
17.8		 5j5xA-2hk5A:
23.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JWA_H_ACTH612_0
(NADH DEHYDROGENASE,
PUTATIVE)		 1cc1 HYDROGENASE (LARGE
SUBUNIT)
(Desulfomicrobium
baculatum) 		3 / 3 ARG L 425
PRO L 424
ASN L 108
 FCO  L 499 (-4.1A)
FCO  L 499 ( 3.5A)
H2S  L 502 (-4.0A)
 0.98A 5jwaA-1cc1L:
0.0
5jwaH-1cc1L:
0.0		 5jwaA-1cc1L:
23.08
5jwaH-1cc1L:
23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KB5_A_ADNA401_2
(ADENOSINE KINASE)		 1jct GLUCARATE
DEHYDRATASE
(Escherichia
coli) 		4 / 4 ASN A 289
LEU A 311
SER A 340
LEU A 148
 GKR  A 499 ( 2.9A)
None
None
None
 1.29A 5kb5A-1jctA:
1.0		 5kb5A-1jctA:
20.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KOX_A_RFPA502_1
(PENTACHLOROPHENOL
4-MONOOXYGENASE)		 3pop GILR OXIDASE
(Streptomyces
griseoflavus) 		5 / 12 GLY A 190
GLY A 102
PHE A 203
GLY A 138
GLY A 137
 None
None
None
FAD  A 499 (-3.5A)
None
 0.84A 5koxA-3popA:
undetectable		 5koxA-3popA:
25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L17_A_ZMRA512_1
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ARG A  37
ASP A  62
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.75A 5l17A-3silA:
13.1		 5l17A-3silA:
22.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L1F_A_6ZPA902_1
(GLUTAMATE RECEPTOR 2)		 1jct GLUCARATE
DEHYDRATASE
(Escherichia
coli) 		4 / 8 ASP A  22
TYR A 164
PHE A 152
SER A  29
 None
None
GKR  A 499 (-4.7A)
None
 1.12A 5l1fA-1jctA:
undetectable
5l1fB-1jctA:
undetectable		 5l1fA-1jctA:
20.20
5l1fB-1jctA:
20.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LW1_H_ADNH401_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 8)		 1k4q GLUTATHIONE
REDUCTASE
(Homo
sapiens) 		5 / 9 GLY A 157
VAL A 332
ALA A 328
LEU A 153
LEU A 298
 FAD  A 499 (-3.4A)
None
None
None
None
 0.95A 5lw1H-1k4qA:
undetectable		 5lw1H-1k4qA:
12.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA504_0
(LACCASE 2)		 2qt6 LACCASE
(Lentinus
tigrinus) 		4 / 4 HIS A 394
CYH A 452
ILE A 454
HIS A 457
 CU  A 499 (-3.1A)
CU  A 499 (-2.2A)
CU  A 499 (-3.7A)
CU  A 499 (-3.1A)
 0.08A 5mejA-2qt6A:
63.6		 5mejA-2qt6A:
66.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA504_0
(LACCASE 2)		 2qt6 LACCASE
(Lentinus
tigrinus) 		4 / 4 HIS A 394
CYH A 452
ILE A 454
HIS A 457
 CU  A 499 (-3.1A)
CU  A 499 (-2.2A)
CU  A 499 (-3.7A)
CU  A 499 (-3.1A)
 0.05A 5mewA-2qt6A:
63.6		 5mewA-2qt6A:
66.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA504_0
(LACCASE 2)		 2qt6 LACCASE
(Lentinus
tigrinus) 		4 / 4 HIS A 394
CYH A 452
ILE A 454
HIS A 457
 CU  A 499 (-3.1A)
CU  A 499 (-2.2A)
CU  A 499 (-3.7A)
CU  A 499 (-3.1A)
 0.05A 5mhuA-2qt6A:
63.6		 5mhuA-2qt6A:
66.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA504_0
(LACCASE 2)		 2qt6 LACCASE
(Lentinus
tigrinus) 		4 / 4 HIS A 394
CYH A 452
ILE A 454
HIS A 457
 CU  A 499 (-3.1A)
CU  A 499 (-2.2A)
CU  A 499 (-3.7A)
CU  A 499 (-3.1A)
 0.05A 5mhvA-2qt6A:
63.6		 5mhvA-2qt6A:
66.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA604_0
(LACCASE 2)		 2qt6 LACCASE
(Lentinus
tigrinus) 		4 / 4 HIS A 394
CYH A 452
ILE A 454
HIS A 457
 CU  A 499 (-3.1A)
CU  A 499 (-2.2A)
CU  A 499 (-3.7A)
CU  A 499 (-3.1A)
 0.05A 5mhwA-2qt6A:
63.6		 5mhwA-2qt6A:
64.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA604_0
(LACCASE 2)		 2qt6 LACCASE
(Lentinus
tigrinus) 		4 / 4 HIS A 394
CYH A 452
ILE A 454
HIS A 457
 CU  A 499 (-3.1A)
CU  A 499 (-2.2A)
CU  A 499 (-3.7A)
CU  A 499 (-3.1A)
 0.05A 5mhxA-2qt6A:
63.6		 5mhxA-2qt6A:
64.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA604_0
(LACCASE 2)		 2qt6 LACCASE
(Lentinus
tigrinus) 		4 / 4 HIS A 394
CYH A 452
ILE A 454
HIS A 457
 CU  A 499 (-3.1A)
CU  A 499 (-2.2A)
CU  A 499 (-3.7A)
CU  A 499 (-3.1A)
 0.05A 5mhyA-2qt6A:
63.6		 5mhyA-2qt6A:
64.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA604_0
(LACCASE 2)		 2qt6 LACCASE
(Lentinus
tigrinus) 		4 / 4 HIS A 394
CYH A 452
ILE A 454
HIS A 457
 CU  A 499 (-3.1A)
CU  A 499 (-2.2A)
CU  A 499 (-3.7A)
CU  A 499 (-3.1A)
 0.06A 5mhzA-2qt6A:
63.6		 5mhzA-2qt6A:
64.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA604_0
(LACCASE 2)		 2qt6 LACCASE
(Lentinus
tigrinus) 		4 / 4 HIS A 394
CYH A 452
ILE A 454
HIS A 457
 CU  A 499 (-3.1A)
CU  A 499 (-2.2A)
CU  A 499 (-3.7A)
CU  A 499 (-3.1A)
 0.06A 5mi1A-2qt6A:
63.6		 5mi1A-2qt6A:
64.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA604_0
(LACCASE 2)		 2qt6 LACCASE
(Lentinus
tigrinus) 		4 / 4 HIS A 394
CYH A 452
ILE A 454
HIS A 457
 CU  A 499 (-3.1A)
CU  A 499 (-2.2A)
CU  A 499 (-3.7A)
CU  A 499 (-3.1A)
 0.05A 5mi2A-2qt6A:
63.6		 5mi2A-2qt6A:
64.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA604_0
(LACCASE 2)		 2qt6 LACCASE
(Lentinus
tigrinus) 		4 / 4 HIS A 394
CYH A 452
ILE A 454
HIS A 457
 CU  A 499 (-3.1A)
CU  A 499 (-2.2A)
CU  A 499 (-3.7A)
CU  A 499 (-3.1A)
 0.05A 5miaA-2qt6A:
63.7		 5miaA-2qt6A:
64.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA604_0
(LACCASE 2)		 2qt6 LACCASE
(Lentinus
tigrinus) 		4 / 4 HIS A 394
CYH A 452
ILE A 454
HIS A 457
 CU  A 499 (-3.1A)
CU  A 499 (-2.2A)
CU  A 499 (-3.7A)
CU  A 499 (-3.1A)
 0.06A 5mibA-2qt6A:
63.5		 5mibA-2qt6A:
64.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA604_0
(LACCASE 2)		 2qt6 LACCASE
(Lentinus
tigrinus) 		4 / 4 HIS A 394
CYH A 452
ILE A 454
HIS A 457
 CU  A 499 (-3.1A)
CU  A 499 (-2.2A)
CU  A 499 (-3.7A)
CU  A 499 (-3.1A)
 0.05A 5micA-2qt6A:
63.6		 5micA-2qt6A:
64.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA604_0
(LACCASE 2)		 2qt6 LACCASE
(Lentinus
tigrinus) 		4 / 4 HIS A 394
CYH A 452
ILE A 454
HIS A 457
 CU  A 499 (-3.1A)
CU  A 499 (-2.2A)
CU  A 499 (-3.7A)
CU  A 499 (-3.1A)
 0.06A 5midA-2qt6A:
63.6		 5midA-2qt6A:
64.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA604_0
(LACCASE 2)		 2qt6 LACCASE
(Lentinus
tigrinus) 		4 / 4 HIS A 394
CYH A 452
ILE A 454
HIS A 457
 CU  A 499 (-3.1A)
CU  A 499 (-2.2A)
CU  A 499 (-3.7A)
CU  A 499 (-3.1A)
 0.06A 5mieA-2qt6A:
63.6		 5mieA-2qt6A:
64.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIG_A_CUA604_0
(LACCASE 2)		 2qt6 LACCASE
(Lentinus
tigrinus) 		4 / 4 HIS A 394
CYH A 452
ILE A 454
HIS A 457
 CU  A 499 (-3.1A)
CU  A 499 (-2.2A)
CU  A 499 (-3.7A)
CU  A 499 (-3.1A)
 0.07A 5migA-2qt6A:
63.7		 5migA-2qt6A:
64.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MO4_A_NILA601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 10 LEU A 251
VAL A 259
GLU A 288
ILE A 314
PHE A 318
MET A 319
GLY A 322
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.9A)
1BM  A 499 (-4.1A)
None
1BM  A 499 (-3.5A)
 1.05A 5mo4A-2hk5A:
26.8		 5mo4A-2hk5A:
29.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MO4_A_NILA601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 10 LEU A 251
VAL A 259
LYS A 273
GLU A 288
ILE A 314
PHE A 318
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.9A)
1BM  A 499 (-4.1A)
 0.77A 5mo4A-2hk5A:
26.8		 5mo4A-2hk5A:
29.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MO4_A_NILA601_2
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 ALA A 271
LEU A 300
VAL A 301
HIS A 362
LEU A 371
ALA A 381
 1BM  A 499 (-3.6A)
None
None
None
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.53A 5mo4A-2hk5A:
26.7		 5mo4A-2hk5A:
29.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MO4_A_NILA601_2
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 ALA A 271
VAL A 291
MET A 292
LEU A 300
VAL A 301
LEU A 371
ALA A 381
 1BM  A 499 (-3.6A)
None
1BM  A 499 ( 3.8A)
None
None
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
 0.75A 5mo4A-2hk5A:
26.7		 5mo4A-2hk5A:
29.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MSD_A_BEZA1202_0
(CARBOXYLIC ACID
REDUCTASE)		 1btc BETA-AMYLASE
(Glycine
max) 		4 / 5 ILE A 299
PHE A 200
SER A 357
ALA A 310
 None
GLC  A 499 ( 3.6A)
None
None
 1.21A 5msdA-1btcA:
2.6		 5msdA-1btcA:
18.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NJV_C_SAMC301_0
(NS5)		 3d1r FRUCTOSE-1,6-BISPHOS
PHATASE CLASS II
GLPX
(Escherichia
coli) 		5 / 12 GLY A 207
GLY A 209
GLY A 214
VAL A 170
ILE A 161
 None
FBP  A3499 ( 4.0A)
None
None
None
 0.94A 5njvC-3d1rA:
undetectable		 5njvC-3d1rA:
25.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NKN_A_LOCA201_1
(NEUTROPHIL
GELATINASE-ASSOCIATE
D LIPOCALIN)		 3snx PUTATIVE SUSD-LIKE
CARBOHYDRATE BINDING
PROTEIN
(Bacteroides
thetaiotaomicron) 		5 / 12 GLY A 418
PHE A 148
LEU A 350
ASP A  77
PHE A 417
 None
None
None
None
EDO  A 499 ( 3.7A)
 1.44A 5nknA-3snxA:
undetectable		 5nknA-3snxA:
13.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5P9I_A_1E8A701_1
(TYROSINE-PROTEIN
KINASE BTK)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 VAL A 259
ALA A 271
ILE A 314
THR A 316
GLY A 322
LEU A 371
PHE A 383
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
None
 0.90A 5p9iA-2hk5A:
24.7		 5p9iA-2hk5A:
40.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TE0_A_XINA401_1
(AP2-ASSOCIATED
PROTEIN KINASE 1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 ALA A 271
MET A 292
VAL A 301
PHE A 318
GLY A 322
LEU A 371
 1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.72A 5te0A-2hk5A:
18.5		 5te0A-2hk5A:
23.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TUD_D_ERMD1201_1
(5-HYDROXYTRYPTAMINE
RECEPTOR 2B,SOLUBLE
CYTOCHROME B562
CHIMERA)		 2qt6 LACCASE
(Lentinus
tigrinus) 		5 / 12 ALA A 389
PHE A 462
VAL A 425
LEU A 450
VAL A 464
 None
CU  A 499 (-4.9A)
None
None
None
 1.11A 5tudD-2qt6A:
undetectable		 5tudD-2qt6A:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TWJ_D_SAMD201_0
(RIBOSOMAL RNA LARGE
SUBUNIT
METHYLTRANSFERASE H)		 3d1r FRUCTOSE-1,6-BISPHOS
PHATASE CLASS II
GLPX
(Escherichia
coli) 		5 / 11 LEU A 233
ILE A 208
GLY A 209
GLY A 210
VAL A 238
 None
None
FBP  A3499 ( 4.0A)
FBP  A3499 (-3.7A)
None
 0.84A 5twjD-3d1rA:
undetectable		 5twjD-3d1rA:
19.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UUN_A_ACTA310_0
(GLUTATHIONE
S-TRANSFERASE-LIKE
PROTEIN)		 1e8c UDP-N-ACETYLMURAMOYL
ALANYL-D-GLUTAMATE--
2,6-DIAMINOPIMELATE
LIGASE
(Escherichia
coli) 		3 / 3 GLU A 468
HIS A 467
ARG A 483
 API  A1499 (-3.1A)
None
None
 0.99A 5uunA-1e8cA:
0.5		 5uunA-1e8cA:
19.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V3D_A_FCNA205_1
(FOSFOMYCIN
RESISTANCE PROTEIN)		 5fzo PROBABLE JMJC
DOMAIN-CONTAINING
HISTONE
DEMETHYLATION PROT
EIN 2C
(Homo
sapiens) 		5 / 10 HIS A2466
THR A2333
TRP A2391
HIS A2336
GLU A2338
 MN  A3499 (-3.4A)
None
None
MN  A3499 (-3.4A)
MN  A3499 (-2.5A)
 1.21A 5v3dA-5fzoA:
undetectable
5v3dB-5fzoA:
undetectable		 5v3dA-5fzoA:
16.47
5v3dB-5fzoA:
16.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VCV_A_1N1A404_1
(MEMBRANE-ASSOCIATED
TYROSINE- AND
THREONINE-SPECIFIC
CDC2-INHIBITORY
KINASE)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 LEU A 251
ALA A 271
LYS A 273
GLU A 288
VAL A 301
THR A 316
 1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
None
1BM  A 499 (-3.2A)
 0.62A 5vcvA-2hk5A:
25.7		 5vcvA-2hk5A:
24.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VCY_A_DB8A401_1
(MEMBRANE-ASSOCIATED
TYROSINE- AND
THREONINE-SPECIFIC
CDC2-INHIBITORY
KINASE)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 LEU A 251
VAL A 259
ALA A 271
LYS A 273
GLU A 288
THR A 316
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.2A)
 0.46A 5vcyA-2hk5A:
25.1		 5vcyA-2hk5A:
24.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VIM_A_SAMA301_0
(METHYLTRANSFERASE)		 3pop GILR OXIDASE
(Streptomyces
griseoflavus) 		5 / 12 GLY A 129
GLY A 137
GLY A 131
HIS A 152
VAL A 392
 FAD  A 499 (-3.6A)
None
FAD  A 499 (-3.5A)
None
None
 0.94A 5vimA-3popA:
undetectable		 5vimA-3popA:
20.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X1F_P_CHDP305_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 3)		 5mc5 XAA-PRO DIPEPTIDASE
(Homo
sapiens) 		4 / 7 HIS A 377
ASP A 453
THR A 410
HIS A 255
 GLY  A 503 ( 3.9A)
None
MN  A 499 ( 4.0A)
PRO  A 504 (-4.2A)
 1.34A 5x1fN-5mc5A:
undetectable
5x1fP-5mc5A:
1.9		 5x1fN-5mc5A:
undetectable
5x1fP-5mc5A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X23_A_LSNA502_2
(CYTOCHROME P450 2C9)		 3d1r FRUCTOSE-1,6-BISPHOS
PHATASE CLASS II
GLPX
(Escherichia
coli) 		3 / 3 LEU A 101
VAL A 189
ASP A 188
 None
None
FBP  A3499 (-2.8A)
 0.58A 5x23A-3d1rA:
undetectable		 5x23A-3d1rA:
20.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X7P_A_ACRA1481_1
(GLYCOSIDE HYDROLASE
FAMILY 31
ALPHA-GLUCOSIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		4 / 6 SER A 343
ARG A  37
GLU A 361
TYR A 342
 None
PO4  A 499 (-2.7A)
None
PO4  A 499 (-4.6A)
 1.19A 5x7pA-3silA:
undetectable		 5x7pA-3silA:
14.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X7P_B_ACRB1431_1
(GLYCOSIDE HYDROLASE
FAMILY 31
ALPHA-GLUCOSIDASE)		 1jct GLUCARATE
DEHYDRATASE
(Escherichia
coli) 		4 / 5 HIS A  32
ASP A 235
GLY A 208
ASN A  27
 GKR  A 499 (-4.0A)
MG  A 498 ( 2.6A)
None
GKR  A 499 (-3.5A)
 1.15A 5x7pB-1jctA:
0.0		 5x7pB-1jctA:
15.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XV7_A_EMHA705_1
(SERINE-ARGININE (SR)
PROTEIN KINASE 1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 12 LEU A 251
GLY A 252
VAL A 259
ALA A 271
ALA A 381
 1BM  A 499 ( 3.7A)
None
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.7A)
 0.37A 5xv7A-2hk5A:
23.6		 5xv7A-2hk5A:
14.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XV7_A_EMHA705_1
(SERINE-ARGININE (SR)
PROTEIN KINASE 1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 12 LEU A 251
GLY A 252
VAL A 259
GLY A 322
ALA A 381
 1BM  A 499 ( 3.7A)
None
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.5A)
1BM  A 499 ( 3.7A)
 0.54A 5xv7A-2hk5A:
23.6		 5xv7A-2hk5A:
14.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y2O_A_8N6A501_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)		 1cc1 HYDROGENASE (LARGE
SUBUNIT)
(Desulfomicrobium
baculatum) 		5 / 12 CYH L 492
HIS L 498
HIS L  77
LEU L 428
LEU L 449
 NI  L 500 (-2.4A)
FE2  L 501 (-3.5A)
FCO  L 499 (-3.9A)
FCO  L 499 (-3.5A)
None
 1.31A 5y2oA-1cc1L:
0.0		 5y2oA-1cc1L:
11.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YU9_D_1E8D1101_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 12 VAL A 259
ALA A 271
GLY A 322
ASP A 326
LEU A 371
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.5A)
None
1BM  A 499 (-4.4A)
 0.49A 5yu9D-2hk5A:
23.7		 5yu9D-2hk5A:
19.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZV2_A_LEVA801_1
(FIBROBLAST GROWTH
FACTOR RECEPTOR 1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		7 / 12 LEU A 251
VAL A 259
ALA A 271
GLU A 288
MET A 292
GLY A 322
ALA A 381
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.5A)
1BM  A 499 ( 3.7A)
 1.05A 5zv2A-2hk5A:
25.2		 5zv2A-2hk5A:
15.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZV2_B_LEVB801_1
(FIBROBLAST GROWTH
FACTOR RECEPTOR 1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		6 / 12 LEU A 251
VAL A 259
ALA A 271
LYS A 273
GLU A 288
MET A 292
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
 0.73A 5zv2B-2hk5A:
25.0		 5zv2B-2hk5A:
15.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AZ3_1_PAR11802_1
(RRNA ALPHA
RIBOSOMAL PROTEIN
UL4
RIBOSOMAL PROTEIN
UL15
RIBOSOMAL PROTEIN
EL15)		 1jct GLUCARATE
DEHYDRATASE
(Escherichia
coli) 		3 / 3 ARG A  99
LYS A 207
ARG A 107
 None
GKR  A 499 (-3.1A)
None
 1.40A 6az3C-1jctA:
0.0
6az3L-1jctA:
0.0
6az3M-1jctA:
undetectable		 6az3C-1jctA:
9.86
6az3L-1jctA:
10.02
6az3M-1jctA:
10.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BSD_A_1N1A901_0
(EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 VAL A 259
ALA A 271
LYS A 273
GLU A 288
MET A 292
THR A 316
MET A 319
GLY A 322
LEU A 371
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.2A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.81A 6bsdA-2hk5A:
30.0		 6bsdA-2hk5A:
16.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6C2M_B_SUEB1202_0
(NS3 PROTEASE)		 1cc1 HYDROGENASE (LARGE
SUBUNIT)
(Desulfomicrobium
baculatum) 		5 / 12 PHE L 420
GLY L 419
ARG L 425
GLY L 252
ALA L 423
 None
None
FCO  L 499 (-4.1A)
None
FCO  L 499 (-3.1A)
 1.15A 6c2mB-1cc1L:
0.0		 6c2mB-1cc1L:
11.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EKU_A_ZMRA901_1
(SIALIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		7 / 12 ARG A  37
ILE A  38
ARG A  56
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
None
None
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.46A 6ekuA-3silA:
36.6		 6ekuA-3silA:
19.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EKU_A_ZMRA901_1
(SIALIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		6 / 12 ILE A  38
ASP A 100
GLU A 231
ARG A 246
ARG A 309
TYR A 342
 None
GOL  A 403 (-3.4A)
GOL  A 402 (-3.3A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.74A 6ekuA-3silA:
36.6		 6ekuA-3silA:
19.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EXI_A_ADNA503_0
(ADENOSYLHOMOCYSTEINA
SE)		 1k4q GLUTATHIONE
REDUCTASE
(Homo
sapiens) 		5 / 10 GLY A  27
GLY A  29
GLU A  50
THR A 156
ASN A 294
 FAD  A 499 (-3.3A)
FAD  A 499 (-3.3A)
FAD  A 499 (-2.8A)
FAD  A 499 (-3.9A)
FAD  A 499 ( 4.5A)
 0.68A 6exiA-1k4qA:
3.6		 6exiA-1k4qA:
9.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EXI_B_ADNB503_1
(ADENOSYLHOMOCYSTEINA
SE)		 1k4q GLUTATHIONE
REDUCTASE
(Homo
sapiens) 		5 / 10 GLY A  27
GLY A  29
GLU A  50
THR A 156
ASN A 294
 FAD  A 499 (-3.3A)
FAD  A 499 (-3.3A)
FAD  A 499 (-2.8A)
FAD  A 499 (-3.9A)
FAD  A 499 ( 4.5A)
 0.71A 6exiB-1k4qA:
4.6		 6exiB-1k4qA:
9.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EXI_C_ADNC503_0
(ADENOSYLHOMOCYSTEINA
SE)		 1k4q GLUTATHIONE
REDUCTASE
(Homo
sapiens) 		5 / 12 GLY A  27
GLY A  29
GLU A  50
THR A 156
ASN A 294
 FAD  A 499 (-3.3A)
FAD  A 499 (-3.3A)
FAD  A 499 (-2.8A)
FAD  A 499 (-3.9A)
FAD  A 499 ( 4.5A)
 0.70A 6exiC-1k4qA:
3.9
6exiD-1k4qA:
4.7		 6exiC-1k4qA:
9.11
6exiD-1k4qA:
9.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EXI_D_ADND503_0
(ADENOSYLHOMOCYSTEINA
SE)		 1k4q GLUTATHIONE
REDUCTASE
(Homo
sapiens) 		5 / 12 GLY A  27
GLY A  29
GLU A  50
THR A 156
ASN A 294
 FAD  A 499 (-3.3A)
FAD  A 499 (-3.3A)
FAD  A 499 (-2.8A)
FAD  A 499 (-3.9A)
FAD  A 499 ( 4.5A)
 0.70A 6exiC-1k4qA:
3.9
6exiD-1k4qA:
4.7		 6exiC-1k4qA:
9.11
6exiD-1k4qA:
9.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6FBV_D_FI8D1904_1
(DNA-DIRECTED RNA
POLYMERASE SUBUNIT
BETA')		 5mc5 XAA-PRO DIPEPTIDASE
(Homo
sapiens) 		4 / 8 ARG A 450
GLU A 412
VAL A 376
ARG A 469
 PRO  A 504 (-3.7A)
MN  A 499 (-2.8A)
None
None
 1.03A 6fbvD-5mc5A:
undetectable		 6fbvD-5mc5A:
undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6FNM_A_1N1A1001_1
(-)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 VAL A 259
ALA A 271
LYS A 273
GLU A 288
ILE A 314
THR A 316
MET A 319
GLY A 322
LEU A 371
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.58A 6fnmA-2hk5A:
27.2		 6fnmA-2hk5A:
40.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6FNM_A_1N1A1001_1
(-)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 VAL A 259
ALA A 271
LYS A 273
MET A 292
ILE A 314
THR A 316
MET A 319
GLY A 322
LEU A 371
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 ( 3.8A)
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
None
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
 0.77A 6fnmA-2hk5A:
27.2		 6fnmA-2hk5A:
40.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HCX_A_ZMRA519_0
(NEURAMINIDASE)		 3sil SIALIDASE
(Salmonella
enterica) 		5 / 12 ARG A  37
ASP A  62
ARG A 246
ARG A 309
TYR A 342
 PO4  A 499 (-2.7A)
GOL  A 403 ( 3.4A)
PO4  A 499 (-2.7A)
PO4  A 499 (-3.0A)
PO4  A 499 (-4.6A)
 0.83A 6hcxA-3silA:
13.1		 6hcxA-3silA:
11.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD4_A_STIA604_0
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		10 / 12 VAL A 259
ALA A 271
GLU A 288
MET A 292
VAL A 301
ILE A 314
THR A 316
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 1.01A 6hd4A-2hk5A:
26.5		 6hd4A-2hk5A:
18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD4_A_STIA604_0
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 VAL A 259
ALA A 271
LYS A 273
GLU A 288
MET A 292
VAL A 301
ILE A 314
THR A 316
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
 0.62A 6hd4A-2hk5A:
26.5		 6hd4A-2hk5A:
18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD4_A_STIA604_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		4 / 5 VAL A 291
PHE A 318
MET A 319
GLY A 322
 None
1BM  A 499 (-4.1A)
None
1BM  A 499 (-3.5A)
 0.70A 6hd4A-2hk5A:
26.5		 6hd4A-2hk5A:
18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD4_B_STIB602_0
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		10 / 12 VAL A 259
ALA A 271
GLU A 288
MET A 292
VAL A 301
ILE A 314
THR A 316
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 1.01A 6hd4B-2hk5A:
26.5		 6hd4B-2hk5A:
18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD4_B_STIB602_0
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		8 / 12 VAL A 259
ALA A 271
LYS A 273
GLU A 288
MET A 292
VAL A 301
ILE A 314
THR A 316
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
 0.64A 6hd4B-2hk5A:
26.5		 6hd4B-2hk5A:
18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD4_B_STIB602_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 6 LEU A 251
VAL A 291
PHE A 318
MET A 319
GLY A 322
 1BM  A 499 ( 3.7A)
None
1BM  A 499 (-4.1A)
None
1BM  A 499 (-3.5A)
 0.95A 6hd4B-2hk5A:
26.5		 6hd4B-2hk5A:
18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD6_A_STIA603_0
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		11 / 12 VAL A 259
ALA A 271
GLU A 288
MET A 292
VAL A 301
ILE A 314
THR A 316
PHE A 318
LEU A 371
ALA A 381
ASP A 382
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 0.99A 6hd6A-2hk5A:
31.7		 6hd6A-2hk5A:
18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD6_A_STIA603_0
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 VAL A 259
ALA A 271
LYS A 273
GLU A 288
MET A 292
VAL A 301
ILE A 314
THR A 316
PHE A 318
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.9A)
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
 0.59A 6hd6A-2hk5A:
31.7		 6hd6A-2hk5A:
18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD6_B_STIB601_0
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 LEU A 251
VAL A 259
ALA A 271
GLU A 288
MET A 292
VAL A 301
THR A 316
PHE A 318
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
 0.93A 6hd6B-2hk5A:
31.5		 6hd6B-2hk5A:
18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD6_B_STIB601_0
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 LEU A 251
VAL A 259
ALA A 271
LYS A 273
GLU A 288
MET A 292
VAL A 301
THR A 316
PHE A 318
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.8A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
 0.65A 6hd6B-2hk5A:
31.5		 6hd6B-2hk5A:
18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD6_B_STIB601_0
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		9 / 12 LEU A 251
VAL A 259
ALA A 271
MET A 292
VAL A 301
THR A 316
PHE A 318
LEU A 371
ASP A 382
 1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
1BM  A 499 (-4.4A)
 0.99A 6hd6B-2hk5A:
31.5		 6hd6B-2hk5A:
18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD6_B_STIB601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 7 VAL A 291
ILE A 314
MET A 319
GLY A 322
ALA A 381
 None
1BM  A 499 (-3.9A)
None
1BM  A 499 (-3.5A)
1BM  A 499 ( 3.7A)
 0.68A 6hd6B-2hk5A:
31.5		 6hd6B-2hk5A:
18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD6_B_STIB601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 2hk5 TYROSINE-PROTEIN
KINASE HCK
(Homo
sapiens) 		5 / 7 VAL A 291
MET A 319
GLY A 322
ARG A 363
ALA A 381
 None
None
1BM  A 499 (-3.5A)
None
1BM  A 499 ( 3.7A)
 0.92A 6hd6B-2hk5A:
31.5		 6hd6B-2hk5A:
18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HWD_K_BO2K301_0
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3d1r FRUCTOSE-1,6-BISPHOS
PHATASE CLASS II
GLPX
(Escherichia
coli) 		5 / 11 ALA A 234
ALA A 263
GLY A 209
GLY A 210
ALA A 211
 None
None
FBP  A3499 ( 4.0A)
FBP  A3499 (-3.7A)
None
 0.85A 6hwdK-3d1rA:
undetectable
6hwdL-3d1rA:
undetectable		 6hwdK-3d1rA:
13.08
6hwdL-3d1rA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HWD_Y_BO2Y301_0
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 3d1r FRUCTOSE-1,6-BISPHOS
PHATASE CLASS II
GLPX
(Escherichia
coli) 		5 / 11 ALA A 234
ALA A 263
GLY A 209
GLY A 210
ALA A 211
 None
None
FBP  A3499 ( 4.0A)
FBP  A3499 (-3.7A)
None
 0.85A 6hwdY-3d1rA:
undetectable
6hwdZ-3d1rA:
undetectable		 6hwdY-3d1rA:
13.08
6hwdZ-3d1rA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6NKN_C_CHDC301_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 3)		 5mc5 XAA-PRO DIPEPTIDASE
(Homo
sapiens) 		4 / 6 HIS A 377
ASP A 453
THR A 410
HIS A 255
 GLY  A 503 ( 3.9A)
None
MN  A 499 ( 4.0A)
PRO  A 504 (-4.2A)
 1.35A 6nknA-5mc5A:
undetectable
6nknC-5mc5A:
2.4		 6nknA-5mc5A:
undetectable
6nknC-5mc5A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6NMP_P_CHDP302_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 3)		 5mc5 XAA-PRO DIPEPTIDASE
(Homo
sapiens) 		4 / 7 HIS A 377
ASP A 453
THR A 410
HIS A 255
 GLY  A 503 ( 3.9A)
None
MN  A 499 ( 4.0A)
PRO  A 504 (-4.2A)
 1.34A 6nmpN-5mc5A:
undetectable
6nmpP-5mc5A:
undetectable		 6nmpN-5mc5A:
undetectable
6nmpP-5mc5A:
undetectable